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ABSTRACT 
Malaria significantly contributes to morbidity and mortality rates in Zambia.  The 
currently accepted malaria treatment is artemisinin-based combination therapy (ACT); it is more 
than 97% effective when the regimen is strictly adhered to.  However, the mean ACT adherence 
rate in sub-Saharan Africa is only approximately 38-48%.  Poor pharmacoadherence remains a 
significant barrier to malaria control and elimination. 
The purpose of this study was to determine if adherence rates to a six-dose ACT 
antimalarial treatment differ between patients in Zambia who received short message service 
(SMS) reminders and those who did not.  
An experimental, randomized, controlled trial was conducted to collect data from a 
sample of 96 adult patients with malaria who presented to Fisenge Clinic in the Copperbelt 
Province of Zambia.   Participants were randomly assigned to a control or intervention group.  
The intervention group received SMS messages to remind them to take their medication 
according to the regimen.  An electronic pillbox was used to measure pharmacoadherence for 
both groups, and patients were classified as probably adherent or probably non-adherent. 
Data were analyzed using Chi-square for association between the SMS intervention and 
pharmacoadherence, and logistic regression used for predictors of adherence.  No significant 
association was found between SMS reminders and pharmacoadherence among malaria patients 
being treated with ACT when evaluated with respect to those who received the SMS reminders 
and those who did not (χ2=0.19, df=1, p=0.67).  Binary logistic regression indicated that there 
were no variables associated with adherence (p>0.05). 
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Findings from this study contribute to the research regarding the use of mobile phones to 
promote adherence.  This is the first study of its kind using SMS directly to the patient for ACT 
adherence in sub-Saharan Africa known to the author.  It is possible that the use of the electronic 
pillbox and/or the novelty of participating in a research study contributed to higher levels of 
adherence than previously found in this geographical area. While data suggested that there was 
no association between SMS and adherence, further research is needed to explore the value of 
this intervention.  
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CHAPTER ONE: THE PROBLEM 
Introduction 
The estimated global toll of malaria in 2012 was 207 million cases associated with 
627,000 deaths (World Health Organization [WHO], 2013).  Eighty-six percent of presumed and 
confirmed malaria cases in the world occurred in Africa with the majority of these in sub-
Saharan Africa.  Zambia, located in the heart of sub-Saharan Africa, is plagued by malaria, 
particularly the Plasmodium falciparum (P. falciparum) species.  The annual number of 
diagnosed and confirmed cases in Zambia, in 2012, was 4.7 million, 2.3% of the total global 
cases, with an estimated 11,000 deaths (WHO, 2013).  Of individuals diagnosed with P. 
falciparum malaria, 90.5% will die if left untreated (Roll Back Malaria [RBM], 2008).  In 
addition to the significant impact on morbidity and mortality, this parasitic infection is estimated 
to cost African countries a total of more than $12 billion annually through diagnosis, treatment, 
and lost productivity, equaling 2-3% of the adjusted Gross National Product of the continent 
(Gallup & Sachs, 2000; RBM, 2003).   
Background 
Detection 
Accurate malaria detection is critical for combatting the disease.  While microscopy is the 
gold standard for diagnosis of malaria, the cost and lack of availability of trained laboratory 
technicians prevent widespread use in resource-limited settings (Murray, Gasser, Magill, & 
Murray, 2008).  Currently, Zambian clinics utilize the rapid diagnostic test (RDT) as the 
accepted diagnostic test.   
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Treatment 
The current pharmacological treatment for uncomplicated P. falciparum malaria, 
recommended by the WHO, is an artemisinin-based combination therapy.  Artemesinin-based 
combination therapy (ACT) utilizes two schizontocidal medications given concurrently with 
independent modes of action to improve therapeutic efficacy and to interrupt the development of 
resistance to the separate components of the blend (WHO, 2006a).  ACT also helps prevent the 
emergence of parasite drug resistance through the interference of asexual replication (White et 
al., 2009; WHO, 2013).  The ACT medication regimen, which has not been modified since 2006, 
consists of six doses to be taken twice daily over three days, with the 2
nd
 dose 8 hours after the 
initial dose which is administered at the clinic and subsequent days’ doses 12 hours apart  
(President’s Malaria Initiative, 2011; WHO, 2006a).  The extent to which one follows the 
prescribed regimen is referred to as adherence or pharmacoadherence.  This regimen is critical 
and has been found to be more than 97% effective when strictly adhered to, resolving clinical 
symptoms even before the regimen is complete (Abdulla et al., 2008; Makanga et al., 2011).  
Artemether-Lumefantrine is the accepted first-line ACT being prescribed in Zambia (WHO, 
2013).  Research shows that giving the second dose of artemether-lumefantrine (AL) 8 hours 
subsequent to the first ensures that the concentration of artemether is sustained above the 
minimum effective concentration level.   This level is necessary in order to maintain the high 
level of exposure of malaria parasites to the medication during the portion of their life cycle in 
which they are most susceptible to anti-malarial agents (Kokwaro, Mwai, & Nzila, 2007; White, 
1992).  
Though researchers have been able to successfully decrease the duration of treatment 
from the 14-day chloroquine treatment to the current 3-day ACT treatment, pharmacoadherence 
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remains a stumbling block in the fight against malaria (RBM, 2010; WHO, 2006a; Yeung & 
White (2005).   
Pharmacoadherence 
Current statistics for malaria treatment pharmacoadherence rates in sub-Saharan Africa 
vary widely in their methods and definitions resulting in a range between 36.5% and 91% (M = 
61.2; SD = 20.0).  Over 50% of studies use self-report as the primary measurement tool and few 
take the timing of the medication into consideration (Ansah, Gyapong, Agyepong, & Evans, 
2001; Cohen, Yavuz, Morris, Arkedis, & Sabot, 2012; Depoortere et al., 2004; Fogg et al., 2004, 
Lawford et al., 2011; Lemma, Löfgren, & San Sebastian, 2011; Okonkwo, Akpala, Okafor, 
Mbah, & Nwaiwu, 2001; Onyango et al., 2012; Yeboah-Antwi et al., 2001).   
Non-adherence not only impacts the patient through suboptimal blood concentrations 
resulting in increased morbidity and mortality, but also impacts the community, through the 
development of parasitic resistance, disease relapse, and increased disease occurrence (Mace et 
al., 2011; White & Olliaro 1996; White et al., 2009).   This problem requires the development of 
a multifaceted approach and enhancement of current strategies to improve pharmacoadherence; 
however, the causes for failure to adhere must first be determined in order to shape effective 
strategies. 
Pharmacoadherence has been associated in part with socio-economic, environmental, and 
demographic differences (e.g. age, education level, ability to read, and household income), as 
well as personal characteristics such as forgetfulness, carelessness, symptom reduction, and the 
side effects associated with the treatment (Morisky, Green, & Levine, 1986; Onyango et al., 
2012; WHO, 2003).  While there has been significant research conducted in order to explore the 
 4 
factors related to pharmacoadherence, this study focuses on variables associated with adherence 
in sub-Saharan Africa.   
Specific attempts to improve pharmacoadherence have included observation, the blister 
pack, and electronic pillboxes such as the Medication Event Monitoring System (MEMS) 
(Kahook, 2007) and SIMpill (2008).  Observation encourages adherence through accountability 
and offers the surest confirmation of pharmacoadherence, but the practicality of observation with 
medication sequences such as the ACT regimen is prohibitive.  Virtual direct observation 
treatment (DOT) is one method using technology for observation that is currently being 
researched (Hoffman et al., 2009).   
When observation proves impractical, blister packs improve pharmacoadherence by 
addressing the forgetfulness aspect through visual cues that indicate whether a patient has taken 
his or her dose.  These pill containers include individually packaged pills in a “blister” or 
“bubble” that is pierced to obtain the pill.  The vacant blister or bubble indicates that the pill has 
been removed, and in pharmacoadherence studies, if the pill is removed the patient is assumed to 
have taken it.  The patient and caregiver can use the blister pack container to verify pill counts or 
to stay on regimen.  While at least two studies using blister packs have resulted in greater than 
95% adherence using blood tests to confirm presence of the drugs, the timing aspect as a critical 
component of ACT treatment is not addressed with this method (Qingjun et al., 1998; Shwe, 
Lwin, & Aung, 1998).  Despite the current use of blister packs, poor pharmacoadherence due to 
forgetfulness, carelessness, symptom reduction or negative side effects continues to thwart 
malaria eradication.  
One electronic pillbox, the MEMS cap, monitors and records the number of bottle 
openings and the date and time of each opening, which can then be downloaded to a computer 
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for analysis.  One prospective descriptive laboratory study verified the reliability of the model of 
MEMS used in this study resulting in 100% perfect functioning with a total absence of missing 
registrations and/or over-registrations (DeBleser, DeGeest, Vandenbroeck, Vanhaecke, & 
Dobbels, 2010).  
The MEMS has been found to motivate pharmacoadherence through accountability, and 
has been determined to be suitable and achievable in a resource-limited setting such as sub-
Saharan Africa (Fallab-Stubi, Zellweger, Sauty, Uldry, Iorillo, & Burnier, 1998; Kahook, 2007; 
Lyimo et al., 2011).  Some of this research, though conducted with anti-retroviral therapy (ART), 
resulted in a 97% (n=23, SD = 4.7) adherence rate in the first month of use, the time period 
relevant to short-term regimens such as ACT (Lyimo et al., 2011).  While MEMS is considered 
to be the imperfect gold standard and more valid than self-report, research indicates that 
pharmacoadherence studies should not rely on MEMS alone, but use multiple adherence 
measures (Cook, Schmiege, McClean, Aagaard & Kahook, 2012; Claxton, Cramer, & Pierce, 
2001).   
An alternative electronic pillbox recently on the market is SIMpill, which electronically 
monitors pillbox openings and sends the data to a remote server.  If the patient does not take 
his/her medication on schedule, SIMpill sends an SMS to the patient and/or healthcare provider 
as a reminder (SIMpill, 2008).  Though little research has been conducted using SIMpill, one 
pilot study implemented in South Africa for tuberculosis (TB) medication adherence resulted in 
increased adherence levels from 83% to 92% (Madyo, 2010).   As a new product, SIMpill data 
and research are limited.  The device has currently been removed from the market in Africa 
halting further research in the current area of focus (Brendan Rens, Director of SIMpill, personal 
communication, August 30, 2013).  
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The American Psychological Association’s recommendations to improve 
pharmacoadherence are summarized in Table 1 (Chisholm-Burns & Spivey, 2008).  These 
recommendations are broad and provide opportunity for further study to determine implications 
to patient outcomes.   The intervention addressed in the current research using mobile phones 
seeks to address forgetfulness as a barrier to adherence.   
Table 1: Summary of American Psychological Association Recommendations to Promote 
Adherence to a Medication Regimen 
Recommendations  
Explain the medication regimen 
Tailor the medication regimen to the patient’s lifestyle and daily routine 
Establish collaborative relationship with patient, and facilitate patient interaction with 
     other pharmacy staff 
Identify and address individual barriers (emphasis added) to adherence 
Refer special-needs patients to appropriate services 
Promote self-efficacy 
Create and maintain an environment conducive to pharmacoadherence 
Mobile Phones 
Recent advancements in mobile phone technology and availability hold promise for 
health research application in sub-Saharan Africa.  Researchers estimate that 65% of all mobile 
phone users can be found in the developing world, with mobile subscriptions in Africa growing 
twice as fast from 2003-2008 as any other part of the world (Gardner, Acharya, & Yach, 2007; 
Hampton, 2012; United Nations Foundation [UNF], 2012).  Over two-thirds of the population in 
Africa is covered by a mobile network, which has resulted in individuals who previously had no 
access to landlines now having access to low-cost handheld devices with SMS capabilities 
(Zurovac, Talisuna, & Snow, 2012).   Eighty-seven percent of urban Zambian households and 
52% of rural households had access to at least one mobile phone in 2008, with expectations for a 
continued rapid rise as the wave of technology floods the continent (Chirwa, 2010).  The three 
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primary mobile phone providers in Zambia are MTN, Zamtel and Airtel with all mobile phones 
in Zambia having SMS capability and the majority operating on pre-paid plans.  All incoming 
phone calls and incoming SMS messages are free to the receiver, which presents an economic 
advantage to the end-user in impoverished areas.  
Statement of the Problem 
Although effective treatment for P. falciparum malaria is available, the problem of poor 
pharmacoadherence remains a significant barrier to malaria control and elimination (Mace et al., 
2011; White & Olliaro, 1996; White et al., 2009).   
Purpose of the Study 
The primary aim of this study was to assess the efficacy of a program to increase the 
pharmacoadherence rate of the six-dose ACT treatment of P. falciparum malaria in the 
Copperbelt Province of Zambia using SMS reminders through the mobile phone.  The secondary 
aim was to gather information through a brief end-of-study questionnaire regarding factors 
affecting pharmacoadherence for further research. 
Question 
For purposes of this study the original hypothesis was converted to a research question at 
the request of the Tropical Diseases Research Centre.  Are SMS reminders sent to patients 
associated with adherence rates to a six-dose ACT antimalarial treatment in the Copperbelt 
Province, Zambia? 
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Original Hypothesis 
 The use of SMS reminders through mobile phones will increase the adherence rate to a 6-
dose ACT antimalarial treatment in Luanshya District, Zambia. 
Assumptions 
 The primary assumptions made in this research are that people desire to be well, that they 
intend to take medication according to regimen in order to become well, and that they do not 
give or sell their medication to others. 
Study Significance 
 Non-adherence to malaria treatment medication continues to impede efforts to eradicate 
malaria in sub-Saharan Africa.  This randomized controlled trial sought to determine if there was 
an association between SMS reminders and pharmacoadherence, as well as exploring the 
possible relationship between demographic factors and adherence.  This research also sought an 
understanding of variables that may be targeted to improve adherence rates, thus addressing 
morbidity and mortality related to malaria.  As such, it offers opportunity for repetition and 
extension to similar studies in this geographical context. 
Definition of Terms 
Some concepts and definitions used in this research necessitate clarification.   Key terms 
used throughout this study are defined in Table 2, including the expansion of their conceptual 
and operational definitions.   
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Table 2: Definition of Terms 
Term Conceptual Definition Operational Definition 
artemether-
lumefantrine 
A fixed-ratio artemisinin-based 
combination of two blood 
schizontocides - artemether with 
lumefantrine - used for the treatment 
of malaria (Bell et al., 2009; White et 
al., 2009).  
 
The currently accepted and 
effective version of ACT for 
P. falciparum malaria in 
Zambia as recommended by 
the World Health 
Organization (WHO, 2012) 
and used by Fisenge clinic. 
 
artemisinin-based 
combination therapy 
A combination of artemisinin or one if 
its derivatives with one or more anti-
malarials of a different class (WHO, 
2006a). 
 
The general name used herein 
for artemisinin-based 
combination anti-malarials. 
complicated malaria 
 
A confirmed diagnosis of a malarial 
infection in an individual presenting 
with symptoms of malaria, with 
evidence of vital organ dysfunction or 
resistance to ACT treatment. 
(WHO, 2006a). 
 
Complicated malaria was 
assessed by unresolved 
symptoms and evidence of 
vital organ dysfunction as 
determined by clinic nurse. 
 
mHealth The use of mobile communication 
devices to provide health-related 
services is referred to as mobile health 
or, in short, mHealth (UNF, 2012) 
 
The use of the mobile phone 
and SMS messaging. 
Medication Event 
Monitoring System  
An electronic pill bottle cap that 
digitally records the time and date of 
each opening for later download to a 
computer for review and analysis.  
 
The MEMS pill bottle cap 
(MWV Healthcare/Aardex 
Solution, 501 South 5
th
 St., 
Richmond, VA 23219) used in 
this study. 
 
pharmacoadherence The extent to which an individual 
follows a medication regimen that has 
been prescribed by the health care 
professional in all aspects of the 
regimen: timing, dosage, method of 
ingestion, etc.
 
 
The measurement of 
adherence to the ACT regimen 
schedule of +/- 1 hour for 2
nd
 
dose and +/- 2 hours for 3
rd
-6
th
 
doses as measured by MEMS. 
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Term Conceptual Definition Operational Definition 
Plasmodium 
falciparum  
The genus and species, respectively of 
one of the protozoan parasites in the 
blood that causes malaria in humans.  
Other Plasmodium (P.) species that 
cause malaria in humans are P. 
malariae, P. ovale and P. vivax 
(WHO, 2006a). 
 
Considered the cause of 
greater than 99% of malaria in 
Zambia as detected by RDTs 
(Centers for Disease Control 
[CDC], 2014). 
 
rapid diagnostic test A test to determine the presence of 
malaria parasites.  An antigen-based, 
finger-prick blood stick for malaria in 
which a colored line indicates the 
presence of plasmodial antigens 
(WHO, 2006a).  The health care 
worker can generally obtain results in 
under 30 minutes. 
 
Test used to detect malaria at 
Fisenge Clinic: ParaHIT f 
RDT by Span Diagnostics, 
Ltd. (173-B, New Industrial 
Estate, Road No. 6-G, Udhna, 
Surat – 394 210, India). 
short message service Another name often used in Africa to 
refer to text messaging with mobile 
phones. 
The intervention used in this 
study to send a reminder to the 
participant that it was time to 
take their medication. 
 
Statistical Package for 
the Social Sciences 
A computer program that analyzes 
and summarizes statistical 
information. 
 
SPSS Version 22.0 for Mac 
was used for the statistical 
analysis. 
Theory of Planned 
Behavior 
A model for understanding and 
seeking to change human behavior as 
developed by Ajzen (2006).  
 
The theoretical framework 
used to guide the current 
research intervention. 
uncomplicated malaria A confirmed diagnosis of a malarial 
infection in an individual presenting 
with symptoms of malaria, without 
evidence of vital organ dysfunction 
(WHO, 2006). 
Positive RDT without 
additional symptoms of 
complicated malaria.  
Preview 
 This research sought to address the problem of poor pharmacoadherence in malaria 
treatment in sub-Saharan Africa.  Chapter 2 contains a summary of a review of the literature 
pertinent to the problem, identifying gaps in the literature to be addressed by the current study, 
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and introduces the guiding theoretical framework.  Chapter 3 details the methods used in the 
research, and chapter 4 presents the findings in terms of the sample demographics, group results 
and other statistical data from the research.  Chapter 5 follows with a discussion of the research 
findings, limitations of the study and recommendations for further research.   
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CHAPTER TWO: REVIEW OF RELEVANT LITERATURE AND 
INTRODUCTION OF THEORETICAL FRAMEWORK 
Review of Literature 
Introduction  
There are numerous studies related to adherence interventions from developed countries, 
many of which are associated with chronic illnesses.  In addition to having limited relevance to 
acute illnesses, these studies are also limited by their cultural context, minimizing 
generalizability.  An exploration of the state of the science using technology for 
pharmacoadherence to a malaria treatment regimen in sub-Saharan Africa was conducted 
through a review of the literature.  An examination of previous research, including definitions of 
adherence, factors influencing adherence and methods of measurement utilized was completed with 
focused attention on sub-Saharan Africa.  
Methods of Search 
A systematic literature review was conducted exploring the use of mobile phones to 
improve pharmacoadherence in the context of sub-Saharan Africa.  Databases searched included 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), MedLine, and Cochrane 
Database of Systematic Reviews from 2005-2013.  Key terms included cell phone or mobile 
phone or mHealth AND adherence or compliance AND health or medication AND Africa or 
sub-Sahara or Zambia or community health workers or malaria.   
While the upstream (the patient to clinician or clinician to government agency) use of 
mobile phones has proven useful in public health programs to monitor disease and communicate 
supply needs to suppliers, the focus of this literature review is on downstream (government 
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agency to clinician or clinician to patient) and peer-to-peer (clinician to clinician or patient to 
patient) use (Asiimwe et al., 2011; Barrington, Wereko-Brobby, Ward, Mwafongo, & Kungulwe, 
2010; Davis et al., 2011; Dean et al., 2012; Kabanywanyi et al., 2010; Kamanga, Moono, 
Stresman, Mharakurwa, & Shiff, 2010; Randrianasolo et al., 2010). 
Criteria for inclusion were that the article’s context was sub-Saharan Africa and that it 
was either associated with pharmacoadherence or that technology was used in a downstream or 
peer-to-peer manner for health-related purposes.  Studies were limited to those published in the 
English language and to current literature due to the recent development of mobile phone 
technology.   
The search resulted in 30 articles.  Of these, two were not health-related adherence; seven 
were not in the sub-Saharan African context; four did not involve the use of technology for 
adherence and eight were either duplicates or clearly irrelevant.  The remaining nine studies were 
included in the literature review.  In addition, 17 other studies were identified through secondary 
searches from the reference lists of selected articles and systematic reviews, resulting in a total of 
25 articles.  Of these, six were systematic reviews, ten experimental studies, seven observational 
analytic studies, one observational descriptive study and one non-research article (see Figure 1 
and Table 3). 
The remainder of this chapter critically reviews contemporary literature regarding mobile 
phone use and adherence in sub-Saharan Africa.  There are a growing number of studies in this 
context with varying degrees of significance.   Following the summary table, a review of articles 
regarding ACT adherence is discussed followed by mobile phones used in health in sub-Saharan 
Africa.  Finally, the two are combined and mobile phone use for adherence is reviewed – first for 
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non-malaria diseases and finally for malaria.  This section concludes with a summary and a 
review of the gaps in the literature.  
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Figure 1: Algorithm for Literature Review 
 
Fail 
Pass 
Databases searched: CINAHL, MedLine, and Cochrane 
Database of Systematic Reviews  
Dates: 2005-2013.   
Terms: (“cell phone” or “mobile phone” or “mHealth”) AND 
(“adherence” or “compliance,”) AND (“health” or 
“medication”) AND (“Africa” or “sub-Sahara” or “Zambia” 
or “community health workers” or “malaria”) 
Initial Results: 30 Articles 
 
21 Excluded  
• 2 not health-related 
• 7 not sub-Saharan Africa 
• 4 not technology for 
adherence 
• 8 duplicates or clearly 
not related 
Inclusion Criteria  
 Associated with 
health-related 
adherence AND  
 Context: sub-Saharan 
Africa AND 
 Technology was used. 
9 Included 
 
25 Total results included 
 6 systematic reviews 
 10 experimental studies 
 7 observational analytic 
 1 observational descriptive 
 1 non-research article 
Add: 16 additional studies identified through 
Systematic Reviews and Reference Lists from 
initial articles 
 16 
Table 3: Literature Review Summary 
Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Bahadur & 
Murray 
(2010)  
Explore use 
of cell phone 
SMS in 
HIV/AIDS 
care in South 
Africa 
N/A: 
Sub-
Saharan 
Africa 
(SSA) -
South 
Africa 
Systematic 
Review 
(28 articles 
in SSA) 
   All 6 RCTs in study 
found significant 
results (p<0.005) 
indicating that SMS 
improve service 
delivery through 
reminders (7 studies) 
and improve 
communication 
between community 
health workers 
(CHW) 
 
Barnighausen, 
et al. (2011)  
Explore 
evidence of 
effectiveness 
of 
interventions 
to increase 
ART 
adherence 
N/A: 
SSA 
Systematic 
Review 
(27 articles 
in SSA) 
   More detailed 
examination of 
evidence needed, but 
initial results indicate 
SMS can be effective 
to increase ART 
adherence in sub-
Saharan Africa; 
Further research on 
theories of adherence 
based on behavior 
change theories is 
needed in SSA 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Chi & 
Stringer 
(2010) 
 
To critique 
research of 
Lester et al. 
Kenya Non-
research 
Study of mHealth, 
Adherence 
  Little outcome data 
available for 
mHealth;  
Comprehensive 
multi-pronged 
approach tailored to 
local settings is 
necessary for 
adherence to ART; 
Estimate < 
$8/yr/patient for SMS 
ART adherence 
reminders in Kenya 
 
Cohen et al. 
(2012) 
Measure 
adherence to 
ACT (AL) 
(over the 
counter) 
N=106 
(2 day); 
152 (3 
day): 
SSA-
Uganda 
Experimen-
tal: 
RCT 
Patients who 
purchased ACT 
randomly assigned to 
1 of 3 grps: 1. No 
follow-up; 2. Follow-
up after 2 days; 3. 
Follow-up after 3 
days. Measure: # pills 
in blister pack or self-
report if unavailable 
3 day: 
32.2% 
(SD=47) non-
adherent; 2% 
(SD=14) 
probably non-
adherent; 
65.8% 
(SD=48) 
probably 
adherent. 
 
Analysis of 
variables 
associated 
with 
adherence: 
Probit 
regressions 
& ordinary 
least 
squares 
regressions 
Pharmacoadherence 
(PA) to ACT in this 
setting = moderate. 
Associated variables 
at p<0.05: 
Some secondary 
education 22% more 
likely to complete tx 
(95% CI [0.063, 
0.38]); 
Able to read English 
had .47 fewer doses 
left [-0.93, -0.003] 
Generalizabi-
lity; small 
sample size; 
some self- 
report 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Crankshaw et 
al. (2010) 
 
Explore 
dynamics and 
patterns of 
mobile phone 
use to 
determine 
feasibility for 
appointment 
reminder and 
adherence 
messages in 
ART 
N=300: 
SSA - 
South 
Africa; 
cross-
sectional 
 
Observa-
tional 
analytic 
Questionnaires 
administered to 
sample and results 
analyzed 
99% willing to 
have verbal 
mobile 
contact; 
96% SMS 
contact; 
# owning 
mobile phone: 
(n=242; 81% 
of sample) 
 
Logistic 
regression: 
OR,  
CI (95%)  
Use of cellphone 
intervention is 
feasible 
Possible 
overstatement 
of patient 
willingness to 
receive mobile 
phone 
reminders due 
to courtesy 
bias; possible 
inaccuracies 
due to recall 
bias; 
generalizability 
Dean et al. 
(2012)  
To determine 
feasibility of 
SMS for 
adherence to 
ART 
N=7: 
SSA – 
South 
Africa 
Experimen-
tal pilot 
study 
Cell phones were 
provided and patients 
invited to SMS each 
other and clinician re: 
HIV, health and 
pregnancy. Four post-
intervention 
interviews were 
conducted 
Collected info 
from 
interviews.  
Overall 
satisfaction. 
Quantita-
tive 
analysis for 
usage 
patterns; 
Qualitative 
for themes 
Group was satisfied 
with the intervention 
and participants 
recommended that 
group be offered in 
the future. 
Pilot study 
 19 
Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
DeRenzi et al. 
(2012) 
To decrease 
the number of 
days that a 
CHW is past 
due with 
routine home 
visits using a 
combination 
of SMS 
reminders and 
supervisor 
informing 
N=87: 
SSA-
Tanza-
nia 
Experimen-
tal 
qualitative 
 
SMS reminders and 
promise of supervisor 
notification to CHWs 
if scheduled home 
visits were late; 
CHWs questioned 
following the studies 
regarding the SMS 
intervention 
Relevant 
outcomes 
related to 
acceptability 
on part of 
CHWs of 
SMS as a 
means of 
reminding 
2 RCTs 
statistical 
results not 
applicable 
to the 
current 
study due 
to multiple 
interven-
tions; 
Follow up 
interviews 
source of 
data 
regarding 
CHWs 
feedback 
CHWs expressed 
positive feedback to 
the use of SMS as 
reminders 
Non-scientific 
study of 
responses 
Donald et al. 
(2007) 
 
Evaluate 
mobile 
phones in 
compliance 
use for HIV 
patients 
N=6:  
SSA – 
South 
Africa 
Observation
al analytic 
qualitative 
Individual interviews 
with councilors using 
technology 2x 6 mo. 
apart 
Generally 
positive and 
strongly 
supported 
 Technology was 
found to be easy to 
use, eased data 
collection, and 
reduced fears around 
losing notes 
Small sample 
size, 
restricted 
setting 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Haberer & 
Kiwanuda 
(2010)  
To examine 
the feasibility 
of using 
interactive 
voice 
response 
(IVR) and 
SMS for 
automated 
collection of 
weekly 
individual 
level ART 
adherence 
data  
N=19: 
SSA – 
Uganda; 
Cross-
sectional 
Experimen-
tal 
mixed 
methods 
IVR and SMS used to 
collect adherence 
data from caregivers 
of children; 
Individual interviews 
to assess participants’ 
impressions of 
technologies 
Participant 
interest and 
participation 
rates were 
high; Weekly 
completion 
rates low (0-
33%)  
Median 
adherence 
rates:  
IVR = 82% 
(95% CI [71, 
92])  
SMS =100% 
[99, 100] 
Logistic 
regression  
Use of IVR and SMS 
in resource-limited 
settings is technically 
feasible. 
Further research 
needed  
Associated variables 
at p<0.05: No 
potential 
characteristics 
associated with 
successful responses 
Low power due 
to small sample 
size and low 
weekly 
completion 
rate; Pill counts 
and MEMS 
adherence rates 
lower than self-
report 
suggesting 
overstatement 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Hoffman et 
al. (2009)  
To assess the 
feasibility and 
acceptability 
among health 
workers and 
patients in 
using video-
enabled 
mobile 
phones to 
monitor 
patient 
adherence to 
TB meds and 
to assess 
patient 
response to 
text and video 
messages via 
mobile phone 
N=13:  
SSA - 
Kenya 
Experimen-
tal 
quantitative 
pilot study 
 
Patients provided 
with video- and text-
ready mobile phones.  
Asked to video 
capture patient taking 
dose at home and 
transmit to central 
database.  Also 
received health 
messages in the form 
of video and text 
messages on phones 
Likert scale 
from 1 
(Awful) to 5 
(Great) rating 
satisfaction 
with study 
procedures 
and 
technology; 
Mean overall 
rating: 4.6 
 All participants 
extremely satisfied  
Pilot study 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Horvath et al 
(2012)  
To determine 
whether 
mobile phone 
SMS 
enhances 
adherence to 
ART in those 
with HIV  
N/A Systematic 
review: 
Meta-
analysis 
(243 
articles; 17 
closely 
reviewed; 2 
in SSA) 
 Any length 
weekly SMS 
reminder 
lowers risk of 
non-adherence 
(RR 0.78, 
95% CI [0.67, 
0.89];  
Short weekly 
SMS better 
than other 
lengths (RR 
0.77, [0.67, 
0.89] 
 Good evidence that 
weekly SMS 
reminders are 
efficacious for 
adherence to ART 
compared to standard 
care 
 
Husler (2005) 
 
To determine 
the effect that 
Compliance 
Service had 
on TB cure 
rates and 
treatment 
completion 
rates. 
To identify 
and describe 
social and 
economic 
impacts. 
To assess 
Compliance 
Service 
N=221: 
SSA - 
South 
Africa 
 
Observa-
tional 
descriptive; 
Retrospect-
ive 
quantitative 
pilot study 
Reviewed patient 
records for cure and 
completion rates. 
Framework used to 
examine social and 
economic impact. 
 
Compliance 
service and 
records could 
not be used to 
measure 
treatment 
adherence 
levels due to 
poor 
implementa-
tion 
procedures 
Insufficient 
data for 
analysis 
Compliance Service 
has potential as cost-
effective system 
Many 
complications 
and obstacles 
in the study 
severely 
limiting 
usability 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Jones et al. 
(2012)  
To investigate 
perceptions 
and 
experiences of 
health 
workers 
involved in an 
RCT to 
improve 
health worker 
malaria case 
management 
N=24: 
SSA - 
Kenya 
Observa-
tional 
analytic 
qualitative 
Individual interviews 
regarding perception 
of message 
intervention in 
Zurovac et al. (2011) 
RCT 
Frequency, 
Length and 
Timing: 
Positive 
Duration: 
Positive 
Messages: 
Positive 
 SMS messaging is 
acceptable and 
effective way of 
providing front line 
health workers with 
active reminders for 
care of malaria 
patients 
Generalizabi-
lity, small 
sample size 
Kaplan 
(2006)  
To look at 
evidence 
regarding the 
idea that fixed 
or mobile 
phones could 
be an 
effective 
health care 
intervention 
in developing 
countries 
N/A Systematic 
review (31 
articles; 2 in 
SSA) 
   Very little literature 
on using mobile 
telephones in 
mHealth for malaria 
in low-resource 
countries; few 
clinical outcomes  
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Kunutsor et 
al. (2010) 
 
To assess the 
use of mobile 
phones in an 
ART cohort 
and ascertain 
feasibility to 
improve clinic 
attendance 
N=276: 
SSA - 
Uganda 
Experimen-
tal 
cross-
sectional 
and 
prospective 
cohort study 
Patients immediately 
reminded by voice or 
SMS if they missed 
appointment; Survey 
provided analysis on 
adherence to ART;  
Adherence support 
strategies 
implemented and 
evaluated 
Mean 
adherence 
levels 
assessed 
before & after 
mobile phone 
reminders 
Before: 96.3% 
(95% CI 
[95.2, 97.4]); 
After: 98.4% 
[97.8, 98.9]; 
(p<0.01)  
Student’s 
paired t test  
SMS text messaging 
and voice calls may 
be timely intervention 
for patient clinic 
attendance, follow-
ups and medication 
adherence in SSA and 
other low income 
settings 
Generalizabi-
lity, design 
limits ability to 
exclude 
confounding 
factors, design 
limits ability to 
reliably 
conclude 
reason for 
those who 
came back (i.e. 
if it was due to 
phone 
reminder or 
not)  
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Lawford et al. 
(2011)  
To measure 
adherence to 
ACT  
N=918: 
SSA - 
Kenya 
Observa-
tional 
analytic case 
study 
Patients treated with 
AL visited at home 4 
days after drug 
prescribed; PA 
measured by 
questionnaire and 
blister packs 
64.1% 
probably 
adherent; 
31.7% 
definitely non-
adherent;  
4.2% probably 
non-adherent 
 
Multi- 
variate 
logistic 
regression 
modeling 
Low AL adherence.  
Associated variables 
at p<0.05: 
Patient age >15 cf 
<15 (AOR 1.37, 95% 
CI [1.02, 1.85]); 
Respondent age 25-
50 cf <25 (AOR 1.65, 
[1.10, 2.48]); 
>1 day delayed (AOR 
0.73, [0.54-0.99]);  
Prior drug use (AOR 
1.46, [1.08, 1.98]); 
Dislikes to 
medication (AOR 
0.62, [0.47, 0.82]);  
>1 correct statement 
re: AL (AOR 1.76, 
[1.32-2.35]) 
Generalizabi-
lity, self-report 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Lemma et al. 
(2011) 
To measure 
patient 
adherence 
levels to 6-
dose AL 
regimen in 
treatment of 
uncomp- 
licated P. 
falciparum 
malaria and 
identify 
factors 
affecting 
adherence 
N=155: 
SSA-
Ethiopia 
Observa-
tional 
analytic case 
study 
Structured 
questionnaire 
conducted at end of 
AL regimen and 
blister packs 
examined 
38.7% 
probably 
adherent; 
34.8% 
probably not 
adherent; 
26.5% 
definitely non-
adherent;  
Univariate 
and 
multiva-
riate 
logistic 
regression 
modeling 
Very low adherence 
to AL raises serious 
concerns for malaria 
control in the region. 
Associated variables 
at p<0.05:  
Radio ownership 
(AOR 3.8; 95% CI 
[1.66, 8.75]);  
Belief in traditional 
malaria tx (AOR 0.09; 
[0.01, 0.78]); Delay 
of >1 day in seeking 
tx after fever onset 
(AOR: 5.39; [1.83, 
15.88]) 
Self-report; 
dose timing 
info not able to 
be accurately 
collected 
Lester et al. 
(2010)  
To determine 
if SMS 
improves drug 
adherence and 
suppression of 
plasma HIV-1 
RNA load as 
supported by 
blood levels 
N=538 
(SMS=2
73; 
Control 
265): 
SSA- 
Kenya 
Experimen-
tal 
RCT 
Weekly SMS from 
clinic nurse to inquire 
about status.  
Instructed to respond 
within 48 hrs. 
RR for non-
adherence was 
.81, (95% CI 
[0.69, 0.94], 
p<0.01) 
SMS=62% 
PA; 
Control=50% 
PA; (OR 0.57, 
95% CI [.40, 
.83], p<0.01) 
Chi square 
test; RR; 
OR 
SMS= Significantly 
improved adherence 
Self-report, 
generalizability 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Mahmud et 
al. (2010)  
To offer 
CHWs mobile 
phones with 
SMS as a 
means of 
communica-
tion rather 
than the need 
for cost and 
time in travel  
N=75: 
SSA-
Malawi 
Observa- 
tional 
analytic 
retrospective 
pilot study 
Group was provided 
cell phones and 
trained in a variety of 
usage (including 
patient adherence 
reporting, 
appointment 
reminders…) 
FrontlineSMS used to 
organize data 
2,048 worker 
hours and 
$2,750 were 
saved and TB 
tx capacity 
was doubled 
Calcula-
tion, 
tallying 
and 
comparison 
mHealth 
interventions can 
provide cost-effective 
solutions to 
communication 
barriers in the setting 
of rural hospitals in 
the developing world 
No bias 
elimination; 
costs of initial 
capital 
investment not 
considered; 
though 
capacity 
doubled, no 
conclusions re: 
outcome 
Odigie et al. 
(2012)  
To determine 
the usefulness 
of mobile 
phones to 
improve 
cancer care in 
low resource 
settings 
N=1176:  
SSA-
Nigeria 
Experimen-
tal 
qualitative 
case study 
Cancer patients who 
had access to cell 
phones were given 
the contact info of 
oncologist and 
encouraged to call 
anytime 
At 24 months, 
97.6% who 
had phone 
intervention 
sustained 
follow-up 
appointments 
vs. 19.2% who 
did not 
Qualitative Confirms the value of 
the mobile phone to 
enhance adherence to 
treatment of cancer as 
well as infectious 
diseases in Africa 
Selection of 
comparison 
group not 
randomized; 
generalizability 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Onyango et 
al. (2012)  
To measure 
adherence to 
ACT; and to 
discover 
factors in 
non-
adherence  
N=297:  
SSA-
Kenya 
Observa-
tional 
analytic 
cross-
sectional 
case study  
Qualitative: 
Individual 
interviews 
Data on adherence 
collected through 
interviews; adherence 
assessed by duration 
of tx and # of tablets 
taken in relation to 
patient age 
Adherence 
rate: Age>13 
42.1%; Age ≤ 
13 57.9%; 
  
Multi-
variate 
logistic 
regression 
analyses; 
Qualitative 
review 
Some demographic 
factors affect 
adherence; More than 
half who get ACT do 
not take 
recommended dose 
and availability is a 
concern. Need 
programmatic 
interventions to 
encourage patient-
centered care.  
Associated variables: 
Low age (OR 0.57, 
95% CI [0.31, 0.91] 
p<0.05);  
Higher education 
level (OR 0.074, 
[0.017, 0.32] p<0.01);  
Ability to read (OR 
0.29, [0.17, 0.49], 
p<0.01); 
Higher income 
>9,000 Kenya 
shillings (OR 0.34, 
[0.17, 0.69], p<0.01) 
Generalizabi-
lity; self-
report; malaria 
not confirmed; 
recall bias 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Pop-Eleches 
et al. (2011)  
To test the 
efficacy of 
SMS 
reminders on 
ART 
adherence  
N=431: 
SSA -
Kenya 
Experimen-
tal 
RCT 
Participants in 
intervention groups 
received SMS 
reminders either long 
or short and sent 
daily or weekly 
Treatment gp 
(SMS) 
Adherence 
decreased 
12% from 
weeks 1-12 to 
weeks 37-48 
compared to 
control gp (No 
SMS) 
adherence 
decreased 
14% (χ2=7.36, 
p<0.01);  
53% patients 
had >90% PA 
with weekly 
SMS 
reminders vs. 
40% patients 
without SMS 
(p<0.05); 81% 
tx 
interruptions 
exceeding 48 
hours with 
weekly SMS 
vs. 90% 
without SMS 
(p<0.05) 
Chi-square 
test & 
logistic 
regression 
SMS reminders may 
be an important tool 
to achieve optimal tx 
response in resource 
limited settings 
Inconclusive 
results; cannot 
corroborate 
adherence with 
viral 
suppression; 
assumption 
that adherence 
in 1 tablet = 
adherence to 
entire regimen 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Yeung & 
White (2005)  
To summarize 
current 
knowledge on 
antimalarial 
adherence, the 
effectiveness 
of 
interventions 
to increase 
usage, and the 
effects of 
drug 
adherence to 
therapeutic 
response 
N/A Systematic 
Review (24 
articles; 13 
in SSA) 
   Overall quality and 
quantity of data 
available very 
inadequate and 
results from studies 
so variable that 
generalizability 
regarding level of 
adherence to 
antimalarials is not 
possible 
 
Zurovac et al. 
(2011)  
To assess if 
SMS 
reminders to 
health 
workers 
improve and 
maintain 
adherence to 
treatment 
guidelines for 
outpatient 
pediatric 
malaria  
N=107:  
SSA-
Kenya 
Experimen-
tal 
Cluster RCT 
Intervention – all 
health workers 
received SMS 
reminders re: malaria 
case-management for 
6 months vs. Control 
– no SMS  
Correct 
management 
of AL 
improved by 
23.7% (95% 
[7.6, 40]; 
p<0.01) 
immediately 
after 
intervention & 
by 24.5% 
[8.1-41.0]; 
p<0.01) 6 
months later 
Descriptive
Difference-
of-
differences 
effect sizes, 
95% CIs & 
p values, & 
confound-
ing 
In resource-limited 
settings, malaria 
control programs 
should consider use 
of SMS to improve 
health workers’ case-
mgmt practices 
Generalizabi-
lity 
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Author: 
(Year) 
Purpose Sample 
size: 
Geogra-
phic 
context 
Type of 
study 
Methodology Outcome 
measures 
Analysis Findings Limitations 
Zurovac et al. 
(2012)  
To review 
studies using 
SMS for 
malaria 
control in 
Africa 
N/A: 
SSA-
Africa 
Systematic 
Review (6 
articles in 
SSA) 
   Scarcity of peer-
reviewed studies and 
lack of evidence to 
determine 
effectiveness of SMS 
for malaria control; 
Suggest 6 areas of 
malaria control in 
which SMS may 
improve delivery of 
services and health 
outcomes including 
pharmaco-vigilance 
and patient adherence 
to medication 
regimens 
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  Results of Search 
ACT Pharmacoadherence 
The pharmacoadherence rates to ACT in two independent studies in sub-Saharan 
Africa demonstrate surprising similarity to each other with a moderate probable adherence 
ranging from 64% to 66% (Cohen et al., 2012; Lawford et al., 2011).   In contrast, other 
studies found that probable adherence fell in the 38-48% range (Gerstl, Dunkley, Mukhtar, 
Baker, & Malkere, 2010; Lemma et al., 2011; Onyango et al., 2012).  The variance is likely 
associated with a stricter definition of probably adherent in the latter three studies, which 
considered not only the consumption of all pills, but the timing of consumption as well.  This 
inconsistency accentuates the failure to achieve comparability in adherence-related 
investigations. 
Health researchers have attempted to identify factors associated with adherence to 
malarial treatment, in order to better identify interventions to improve adherence, and have 
had widely varying results.  Three studies identified several variables, which are often linked 
with a more affluent socio-economic status, that were found to be associated with adherence 
including monthly income, education level achieved, radio ownership and literacy (Cohen et 
al., 2012; Lemma et al., 2011; Onyango, et al., 2012).  Though income, education level and 
literacy are easily explained factors, radio ownership has raised some questions.  One 
possible explanation for association with radio ownership could be exposure to the national 
anti-malarial initiatives promoted through the media.  Lemma et al. (2011) also identified the 
belief that malaria can be treated traditionally (without medication) as a factor associated 
with lower adherence.  Another factor found in two independent studies in Kenya to be 
associated with ACT adherence was age, though the findings appeared to contradict each 
other.  One study found that younger (<13 years) participants adhered better, while the other 
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found that older (25-50 years) participants had better adherence, though the former results 
may be related to the attentiveness of the caregiver to ensure that children received 
medication (Lawford et al., 2011; Onyango, et al., 2012).  Seeking treatment more than one 
day after the onset of fever was also linked to adherence although in one study it increased 
adherence, while in the other it decreased the adherence rate (Lawford et al., 2011; Lemma et 
al., 2011).  Lawford et al. (2011) also discovered that several factors related to the patient’s 
knowledge and exposure to the drug were significant.  The wide range of differences in the 
identified factors linked with adherence appears to be due to the inclusion of dissimilar 
aspects in studies and/or the disparate definitions of those items studied.  Again, lack of 
uniformity in definitions and in measurement instruments presents a challenge, limiting 
comparability among studies. 
While some researchers have focused on finding factors associated with adherence, 
others have identified barriers preventing or impeding better rates.  Some reasons given for 
low rates of pharmacoadherence are forgetfulness and inattentiveness to the regimen 
schedule.  Two researchers found that symptom reduction and negative side effects 
associated with the treatment may also lead to early cessation of the regimen (Morisky et al., 
1986; Jones et al., 2012), while others indicated that early resolution of symptoms resulted in 
better adherence rates (Depoortere et al., 2004; Fogg et al., 2004; Yeung & White, 2005).   
The search for factors associated with adherence can lead to possible interventions to 
improve it.  Many of the demographic factors that are linked to adherence such as education, 
literacy and income require long-term, socio-economic changes.  Recent studies, however, 
have been conducted to assess the effectiveness of possible interventions that could be 
implemented to produce immediate improvements in adherence such as the presentation and 
packaging of the medication.  These interventions include a formulation study in which 
tablets resulted in 91% adherence compared with only 42% using syrup (Ansah et al., 2001).  
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In a packaging study, the dosages that were pre-packaged improved adherence from 60.5% to 
82% for tablets and from 32.5% to 54.3% for syrup (Yeboah-Antwi et al., 2001).  Provider 
instructions in a third study improved adherence significantly from 36.5% when no 
instruction was given to 51.9% for pictorial insert only, and to 73.3% for pictorial insert plus 
verbal instruction (Okonkwo et al., 2001).  These results utilizing simple, low-cost, short-
term interventions offer incentive for further exploration and investigation.  
Adherence to malarial treatment continues to present a multi-faceted challenge.  The 
plurality of factors and results from adherence studies indicate a strong need for further study 
and standardization.  The rapid expansion of technology offers great opportunity for 
innovative research to address some of these areas. 
Mobile Health  
The recent rise in technology and mobile phone use in Africa offers an unlimited 
number of resources for multiple healthcare applications to a wide range of diseases.  
mHealth, the common name given to mobile technology used for healthcare, is expanding as 
quickly as the technology it utilizes.  Studies exploring the patterns of mobile phone use in 
sub-Saharan Africa have found the response to the use of cellphones in healthcare to be very 
positive and cost-effective (Crankshaw et al., 2010; Dean et al., 2012; DeRenzi et al., 2012; 
Donald, Ulrike, Charissa, & Skinner, 2007; Hoffman et al., 2009; Jones et al., 2012; 
Kamanga et al., 2010; Odigie et al., 2012).  Results indicate that as many as 99% of 
healthcare clients were willing to have verbal mobile clinical contact, and 96% were willing 
to have SMS contact (Crankshaw et al., 2010).   Study participants have cited ease of use and 
reduced travel time as primary incentives for mobile phone use (Crankshaw et al., 2010; 
Odigie et al., 2012).    
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While some mHealth interventions focus on voice communication, SMS offers the 
lowest cost mobile phone approach and therefore one of the best alternatives in a resource-
limited setting.  SMS interventions have been used to attempt to improve the delivery of 
health services by reminding patients of appointments, assisting with communication 
between health care workers, promoting health, improving pharmacoadherence, and offering 
accountability (Bahadur & Murray, 2010; Barnighausen, Tanser, Dabis, & Newell, 2011; 
DeRenzi et al., 2012; Husler, 2005; Zurovac, 2011).   
One pilot study in Malawi measured the effects of SMS communication among 
CHWs for purposes such as adherence reporting and appointment reminders.  The focus was 
on financial and labor hour savings, which were substantial over a 6-month study ($2,750 
net; 2,048 hours of worker time), and resulted in an increase in productivity for healthcare 
providers (Mahmud, Rodriguez, & Nesbit, 2010).  
Other preliminary studies that suggest promising results in the use of SMS utilize 
mobile phones for upstream cancer care adherence and downstream reminders to CHWs to 
adhere to the prescribed home-visit schedule (DeRenzi et al., 2012; Odigie et al., 2012).  One 
of these studies discovered that at 24 months, 97.6% of cancer patients who had been given 
the contact information of their doctor and encouraged to call had continued with their 
follow-up appointments compared with only 19.2% of those who had not been given the 
physician’s phone number (Odigie et al., 2012).  While the other study had no quantitative 
statistical evidence relevant to this study, they received positive feedback to mobile phone 
use with CHWs (DeRenzi et al., 2012). 
One unique interaction using mobile phones in South Africa connected patients not 
only to caregivers, but also to each other, in order to offer community support in a largely 
collective society.  Pregnant women diagnosed with HIV were invited to use SMS to 
communicate with the nurse or with each other about health-related questions and to offer 
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one another support and/or advice.  The response of the participants to an open-ended 
questionnaire was very positive, with patients expressing the experience of 
interconnectedness and increased disease-related knowledge (Dean et al., 2012).  
Kaplan’s (2006) review of the literature provides evidence that can either support or 
refute the hypothesis that phones can be effectively used in healthcare intervention in low-
resource countries.  The review indicated a gap in the literature regarding the use of mobile 
phones to address HIV, tuberculosis, malaria, and chronic conditions in developing countries, 
as well as a lack of measured clinical outcomes and quality studies.  However by 2012, four 
literature reviews noted in this study indicated that research exploring SMS for healthcare is 
increasing rapidly.  Three of those four reviews (28+ articles) focus on ART adherence with 
only a single literature review focusing on antimalarial adherence comprised of a mere six 
articles (Bahadur & Murray, 2010; Barnighausen et al., 2011; Horvath, Azman, Kennedy, & 
Rutherford, 2012; Zurovac et al., 2012).   
These studies represent a broad use of mobile phones and a broad range of results.  
Overall results indicate that mHealth is emerging as a potential gold-mine of innovations, 
containing limitless applications and opportunity for further research including interventions 
to improve pharmacoadherence in general and ACT in particular. 
Mobile Phones to Improve Adherence 
Non-Malaria 
The majority of the research on mobile phone use for adherence in sub-Saharan 
Africa focuses on ART adherence in South Africa, a country that is arguably the most 
technologically advanced in this geographic context (Bärnighausen et al., 2011; Chi & 
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Stringer, 2010; Crankshaw et al., 2010; Dean et al., 2012; Donald et al., 2007; Haberer & 
Kiwanuda, 2010; Lester et al., 2010; Pop-Eleches et al., 2011). 
Mobile phones applied to pharmacoadherence provide a variety of interaction 
methods for communication ranging from SMS on the simple end to virtual DOT via mobile 
phone video transmission on the more complex.  All of the articles mentioned above include 
SMS as one potential intervention, indicating the broad awareness of the growing 
possibilities and affordability of this simple application. 
Often SMS is explored in parallel with other interventions.  One innovative study 
used both IVR and SMS to collect adherence information from caregivers of children 
infected with HIV in Uganda.  This qualitative study determined that, while the rates of 
interest and participation were high, the completion rate for questionnaires was low (0-33%) 
possibly because of the new nature of IVR in this cultural setting.  This was the only study 
found in sub-Saharan Africa using IVR for medication adherence.  The authors suggest that 
the use of IVR and SMS is technically feasible, however setup costs for more complex uses 
of technology such as IVR need to be considered and may prove prohibitive in resource-
limited settings (Haberer & Kiwanuka, 2010). 
Most research regarding mobile phones and adherence utilized the cheapest, simplest 
and most common means of communication via mobile phone - SMS or simple phone calls – 
to remind the patient directly to take their medication.  Kunutsor et al. (2010) addressed 
medication adherence indirectly by reminding patients through voice and SMS about missed 
clinic appointments, which included the patient picking up their medication refills.  
Adherence levels were assessed to determine the effect of reminders on optimal adherence.  
Mean adherence was determined to be significant with 96.3% before and 98.4% after mobile 
phone intervention.  
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Two systematic reviews were found to specifically explore mobile phone use in sub-
Saharan Africa associated with ART adherence (Bärnighausen et al., 2011; Horvath et al., 
2012).  Within these reviews, two RCTs from Kenya compared the adherence of those with 
SMS communication to those without SMS.  In both studies, the use of a short weekly SMS 
reminder resulted in improved rates of adherence (53-62%) when compared to the control 
group without reminders (40-50%).   In addition, one study explored the effectiveness of 
different lengths and frequencies of SMS.   Both studies found that SMS reminders were 
associated with increased adherence, and a short weekly SMS was found to be more effective 
than other lengths and frequencies (Lester et al., 2010; Pop-Eleches et al., 2011).  Findings 
also included a decrease in treatment interruption in those receiving weekly reminders (81%) 
compared with the control group (90%) (Pop-Eleches et al., 2011).  There is significant 
evidence validating the use of SMS reminders to increase adherence to ART in sub-Saharan 
Africa, however Chi and Stringer (2010) suggest that a multi-faceted approach tailored to 
local settings may prove more effective than any single intervention. 
Studies using mobile phones for adherence are not restricted to HIV medications nor 
are they limited to low-tech applications of mobile phones.  Hoffman et al. (2009) conducted 
a pilot study in Kenya to assess the feasibility and acceptability of mobile phones to monitor 
TB adherence through upstream video reporting.  They offered video-enabled mobile phones 
to 13 patients, and trained a health care assistant in the home to video the patient taking their 
TB medication.  These data were then immediately transmitted to a central database where 
healthcare workers observed them as required by DOT protocol.  The investigators also sent 
video and SMS health messages downstream to the patients.  The patients completed a brief 
questionnaire at intake, after 15 days and at one month after intake asking them to rate their 
experience.  The results indicated a mean response of 4.6 on a 5-point Likert scale from 1 
(“Awful”) to 5 (“Great”) suggesting that participants were very satisfied with study 
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procedures and technology.  Mobile phone technology is becoming a viable alternative to 
direct observation offering a virtual DOT in some areas where mobile phone videos can be 
sent. 
One service in South Africa sends SMS downstream to patients to remind them to 
take their TB medication according to regimen.  One pilot study of the company evaluated 
the use of the reminder service on TB recovery to identify socio-economic impacts of 
technology in that context, and to conduct an assessment of the management of the project.  
While the treatment outcomes involving the SMS intervention were comparable to clinical 
outcomes, the results were not statistically significant.  Nevertheless, the authors conclude 
that the use of SMS for medication reminders offers a cost-effective potential resource to 
complement clinical care (Husler, 2005). 
Much of the non-malaria research utilizing mobile phones for adherence has 
implemented similar techniques using SMS direct to patients for reminders and many of them 
offer hope for achievable wide-spread results.  Studies have not produced statistical 
significance across the board, but many suggest promise for new implementations and 
continued research. 
Malaria 
Only six studies were found using SMS for malaria control in Africa with five of 
these focusing on upstream uses such as disease surveillance or commodity monitoring 
(Zurovac et al., 2012).  The only RCT discovered using downstream SMS reminders for 
malaria treatment in sub-Saharan Africa is that of Zurovac et al. (2011) in which SMS are 
sent to CHWs.   
In more developed nations, a team of health care professionals including nurses, 
physicians and pharmacists conducts the role of health care.  In sub-Saharan Africa, CHWs 
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or medical assistants (comparable to a nurse practitioner) function independently, diagnosing, 
prescribing and monitoring treatment, generally with no involvement from others (Rueda, 
2008).  Resource-intensive interventions directed towards the individual have been 
considered difficult to implement in sub-Saharan Africa due to the large numbers of patients 
and limited number of health providers (Safren et al., 2012).   Therefore, research to date has 
focused primarily on adherence interventions to the provider of the medication.   
The Kenyan study conducted by Zurovac et al. (2011) assessed the effectiveness of 
SMS malaria case-management reminders from primary investigators (PI) to HCWs in 
promoting adherence to standard malaria treatment.  While the standard care protocol for 
malaria is relatively simple, it is challenging to ensure that practice conforms to the standard, 
so SMS messages consisting of educational reminders related to the ACT regimen were sent.  
The study revealed an improved adherence to medication guidelines by 23.7% immediately 
after intervention, with a 6-month improvement rate of 24.5%.  In a follow up article to the 
RCT, Zurovac et al., (2012) confirmed that non-adherence is a major area of deficiency in the 
treatment of malaria, and they support the idea that SMS is potentially beneficial in 
increasing pharmacoadherence.  In a qualitative study examining Zurovac’s research, the 
authors found that there was a high acceptance of all the aspects of the intervention using 
SMS as reminders to bring about behavioral change (Jones et al., 2012).   
While the research of Zurovac et al. (2011) and Jones et al. (2012) involved SMS to 
malaria HCWs rather than the patient, Lester et al. (2010) and Pop-Eleches et al. (2011) have 
also demonstrated that SMS interventions directly to the patient can be effective, though their 
research focuses on ART adherence.  No studies were discovered that utilized SMS directly 
to patients for ACT pharmacoadherence in sub-Saharan Africa indicating a significant gap in 
the literature and research.  The current study offers an attempt to address this gap and 
change adherence behavior. 
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Theoretical Framework 
Introduction 
The National Malaria Control Center of Zambia states that the primary goal of the 
national communication strategy “…is to facilitate positive behavior change (emphasis 
added) and capacity building through the provision of correct and relevant information to 
empower people for more effective decision-making in health” (National Malaria Control 
Center, 2012, “Behavior Change” para. 2).  Addressing the many factors affecting adherence 
can be overwhelming, however the singular focus is on changing behavior.  If one’s behavior 
in taking medication can be altered, pharmacoadherence rates can be improved.  A theory 
addressing the needed change is essential to underlie continuing attempts to improve health 
habits. 
The theoretical framework underlying the suggested intervention is the Theory of 
Planned Behavior.  The Theory of Planned Behavior (TPB) is a social cognitive model 
credited to Icek Ajzen as an extension of his and Fishbein’s Theory of Reasoned Action, and 
incorporates aspects of Bandura’s Theory of Self-Efficacy (Ajzen, 1988; Fishbein & Ajzen, 
2010; Kuhl & Beckman, 1985).  This theory (see Figure 2) provides the most relevant 
framework for implementing the targeted intervention for improving antimalarial 
pharmacoadherence through planned behavioral change using SMS messages.  
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Figure 2: Theory of Planned Behavior 
Adapted from “Theory of Planned Behavior,” by Icek Ajzen, 2006, retrieved from Icek 
Ajzen, TPB, http://people.umass.edu/aizen/tpb.diag.html.  Used by permission as stated on 
website. 
 
The TPB postulates that there are three constructs that guide behavior.  The first 
construct is that of behavioral beliefs, involving the individual’s beliefs about the expected 
outcomes of a particular behavior.  The collective behavioral beliefs result in a particular 
favorable or unfavorable attitude towards the behavior.   The second, normative beliefs, 
focuses on the perceived expectations of significant others and one’s motivation to meet 
those expectations.  The collective normative beliefs comprise a subjective norm or social 
pressure to behave or not to behave in a certain manner.  The third and final construct, control 
beliefs, measures the perception of factors that may facilitate or inhibit this behavior, and the 
perceived power inherent in those factors.  Collective beliefs about control result in a 
perception of the amount of control one has over one’s own behavior.  The sum of these three 
outcomes – behavioral attitudes, subjective norms and perceived control - results in a level of 
intention, which, if sufficiently significant, generally results in the desired behavior. 
Increasing any one of these constructs increases the level of intention, which in turn increases 
the likelihood of the individual carrying out the behavior (Ajzen, 2006).   
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For an intervention using TPB to be successful in the long term, it will likely focus on 
one or more of the factors that affect the intention and therefore the behavior:  Attitude 
toward the behavior, subjective norms and/or perceived control over behavior.  Because each 
of these is grounded in corresponding beliefs, the most effective and lasting change will 
address the belief system itself, though this is also the most difficult level to address and 
involves prolonged commitment to change (Ajzen, 2006).  This theory has great potential for 
long-term future research and exploration of beliefs and attitudes to discover factors affecting 
pharmacoadherence for malaria treatment in Zambia.  The current intervention, however, 
offers a short-term method for addressing one aspect of the theory through focusing on 
barriers that limit actual behavioral control. 
While perceived control is a critical element in the TPB, there can be barriers to the 
execution of a behavior, making actual control less than perceived control.  These barriers 
may interrupt one’s intention, preventing the individual from carrying out the behavior.   This 
limit on volitional control indicates that the actual control that one has over a behavior, rather 
than merely the perceived control, is what determines the resultant action (Ajzen, 2006).  
While the TPB offers a sound framework for interventions to promote pharmacoadherence, 
some concerns and opposition appear in the literature. 
The SMS Intervention within the Theoretical Model 
Patients generally believe that they control their ability to adhere (control beliefs).  
The patient’s beliefs lead to the perception that they can and will have control to adhere to the 
prescribed regimen because of their desire to be well, and the perception of the benefits of 
good health (perceived behavioral control). 
When focusing on the right hand side of the TPB model (see Figure 3), it is evident 
that an individual’s likelihood of engaging in adherent behavior correlates with the strength 
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of the intention to actually adhere, assuming that barriers do not prevent the intention from 
resulting in actual adherent behavior.  Barriers interfere with, and therefore decrease actual 
control.  Some of the barriers to regimen adherence that are identified in the literature review 
are:  Forgetfulness, the medication having a bad taste, the negative side effects (e.g. nausea, 
vomiting) caused by the medication, and tendency to quit taking the medication when 
symptoms subside.  The intervention of SMS used in this study sought to overcome some of 
the barriers to adherence by providing both a reminder to address forgetfulness and 
encouragement to complete the regimen.  In addition, the study included a short questionnaire 
collecting information that may prove helpful in the more difficult task of initiating long-term 
change in beliefs that can bring about deep-seated, long-term change in behavior.  
 
Figure 3: Detail of Figure 2: SMS to Address Barriers 
Adapted from “Theory of Planned Behavior,” by Icek Ajzen, 2006, retrieved from Icek 
Ajzen, TPB, http://people.umass.edu/aizen/tpb.diag.html.  Used by permission as stated on 
website. 
Critique of the TPB 
While no objections specifically to the TPB for pharmacoadherence in sub-Saharan 
Africa were discovered, some general objections to the efficacy of the model exist.  Ogden 
SMS Intervention 
Barriers preventing 
perceived behavioral 
control from becoming 
actual behavioral control 
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(2003) expresses several concerns:  He posits that models of social cognition cannot be tested 
because they cannot be proven false; he insists that the relationships between the model 
components are true by definition, therefore ensuring a strong correlation; he asserts that the 
questionnaires to test the constructs might actually cause and influence cognitions that impact 
behavior rather than merely assessing them.  
The TPB would, however, be proven false if all three constructs of the model failed to 
predict intention, which research has not indicated (Ajzen & Fishbein, 2004).  The constructs 
have been validated in equation analysis and in other investigations that have tested the 
validity of the construct, and the evidence indicates that assessment methods do not 
significantly affect the cognitive constructs in the TPB (Ajzen & Fishbein, 2004). 
Some critics question the assumptions of all reasoned action theories, a category into 
which the TPB falls.  Wegner (2002) doubts the significance of consciousness as an agent of 
causation.   Greenwald and Banaji (1995) believe behavior to be driven by implicit attitudes 
while others (Aarts & Kijksterjuis, 2000) suggest that behavior is a result of other mental 
processes, of which a person is not conscious.  These objections do not lend themselves to 
clear empirical verification. 
Critics also claim three other limitations of the model.  Some researchers question the 
sufficiency of the model or suggest that the limits inherent in it are too great.  Another of the 
criticisms of TPB is that it does not account for affect and emotions, that the model is too 
rational, while yet another argument suggests that the TPB is not sufficient to explain 
behavior.  Critics claim that other components should be added, but rarely agree about which 
component(s).  Ajzen (2011) addresses these concerns.   
Regarding the limits of predictive validity in terms of correlations among constructs, 
the best that can be reasonably expected in this type of model is around 0.6, a measure that 
approximates the results in the studies he references.  
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The TPB does not assume that beliefs are formed rationally.  The “planned” nature of 
the behavior does not refer to a rational belief basis, but rather to the nature in which beliefs 
lead to attitudes that influence intention and, ultimately, impact behavior.  Affect and 
emotions serve as foundational factors to beliefs, and as influencers to direct which beliefs 
within our memories affect one’s attitude or intention (Ajzen, 2011).  
Ajzen and Fishbein (2004) expect further developments in the model and provide 
guidance for the criteria that any additions would need to meet, while rejecting any specific 
additions proposed to date based on failure to comply with said criteria.  
Population of Interest 
  One of the primary objections is that the TPB is individualistic and therefore not 
applicable to more communal societies such as those found in sub-Saharan Africa (Campbell, 
2003; Kagee & van der Merwe, 2006).  Fishbein (2002) indicates that, when properly 
applied, this model is in fact sensitive to cultural differences, since it incorporates the belief 
system of the population being observed.  For example, communal influence would be 
addressed in the TPB in the normative beliefs construct. 
Since there is room within the model for considering cultural differences, applying the 
TPB to pharmacoadherence in sub-Saharan Africa has integrity.  In one study in South 
Africa, TPB significantly explained variance in patients’ intentions and behavior related to 
adherence.  TPB variables explained 47% of the variance in adherence intentions, resulting in 
a large effect (Kagee & van der Merwe, 2006; Polit & Beck, 2004).   When combined, 
attitudes and perceived behavioral control explained 23% of the self-reported 
pharmacoadherence variance.  While TPB was found to only explain a portion of adherence 
intentions in the sample, the strongest predictor of pharmacoadherence intentions was 
perceived behavioral control (β=0.59), indicating that improving the perception of behavioral 
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control may be an effective way to increase pharmacoadherence (Armitage & Conner, 2001; 
Kagee, 2008).  Offering the patient a reminder by SMS is likely to increase the perception of 
behavioral control as well as to overcome the barrier of forgetfulness thus increasing actual 
behavioral control.  The end result would be an increased probability of the desired behavior.   
The TPB provided a sound theoretical model for the current research. 
Summary of the Literature Review and Theoretical Framework  
Overall, the literature review indicates that SMS is efficacious in enhancing 
pharmacoadherence, offering the potential to be effective in malarial treatment in sub-
Saharan Africa and hence result in a greater recovery rate and decreased drug-resistance. This 
innovation is a powerful method to disperse information, offering an effectual, simple and 
low-cost application of technology to reach a population in a timely and efficient manner 
(Gardner et al., 2007; Zurovac, et al., 2011).  Nevertheless, the use of SMS to initiate 
behavioral change in health is in the early stages of exploration, and there is very little 
evidence-based research of the use of this technology directly to patients to address 
pharmacoadherence behavior in sub-Saharan Africa (Hampton, 2012; Zurovac et al., 2011).  
No studies were found using this specific application for malaria.  This inspires continued 
attention to this area of research.  
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CHAPTER THREE: METHODS 
Introduction and Design 
 This chapter presents the methods used in this study beginning with the design, 
sample and setting, population and inclusion/exclusion criteria.  In addition, the precautions 
for working with human subjects are identified and the intervention and instruments used are 
explicated.  Finally, the procedures and the statistical analysis for the study are described. 
This prospective, quantitative, randomized controlled trial was an experimental, 
between-groups design.  Pharmacoadherence was the dependent variable and the SMS 
intervention was the independent variable.  
Sample and Setting 
The convenience sample was comprised of individuals who presented to the public 
clinic in Fisenge, Zambia, tested positive for uncomplicated P. falciparum malaria, and met 
inclusion criteria.  The setting for this study was the rural village of Fisenge, Zambia located 
just off the Luanshya Road close to the Ndola/Kitwe road in the Copperbelt Province.  
Fisenge has a population of 13,000 with a household income below the national average of 
USD $1,200/year (Zambia Census of Population and Housing, 2000).  Fisenge is 
representative of rural villages in the Copperbelt Province, with the majority of citizens 
educated in the public schools where, up until 2014, all education was delivered in English.  
This site was chosen based on the large number of patients diagnosed with malaria according 
to clinic records during a site visit in 2012.   
Population 
The target population of this study was rural Zambians over 18 years of age who were 
at least minimally literate in English, and who were diagnosed with uncomplicated P. 
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falciparum malaria.  Literacy is defined by the United Nations as being able to read and write 
a short and simple statement about every day life, a definition that 70% of Zambians meet 
(United Nations Development Programme, 2011).  The term “minimally literate” used in this 
study indicates an ability to read sample phrases, which are similar to those that were sent by 
SMS.  
Inclusion/Exclusion Criteria 
To be included in the proposed study, participants must have been at least 18 years of 
age; had continuous access to a mobile phone for the three days following their clinic visit; 
were able to communicate via SMS; and were able to read three health-related phrases 
chosen from a selection of those that were sent by SMS.  Participants were excluded if 
another member of the household was already a part of the study.  In addition, if potential 
subjects had been treated for malaria in the two weeks immediately prior to their 
presentation, they were excluded.  While the original exclusion criteria also included a 
recorded fever more than 24 hours before clinic visit in order to avoid complicated malaria 
cases, none of the participants had records of fever measurement.  
Sample Size 
For the purpose of this study, a medium effect size for a Chi-square analysis and 
bivariate linear regression was assumed for the intervention.  An apriori power analysis was 
conducted using G*Power (ver. 3.1.6) to determine sample size to provide a medium effect 
size (.30), with a level of significance of α = .05, and power of .80 (Cohen, 2003; Faul, 
Erdfelder, Lang, & Bucher, 2009).  The computation resulted in a required sample size of 88.  
A targeted sample size of 126 was determined to allow for attrition and incomplete data.   
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Ethical Considerations 
Protection of Human Subjects 
Provisions to insure safety of participants were maintained through the adherence to 
legal and ethical institutional review board (IRB) policies of the University of Central Florida 
(see Appendix F), as well as those of the Tropical Diseases Research Centre (TDRC) in 
Ndola, Zambia (see Appendix G) as directed through the Zambia Ministry of Health (see 
Appendix H).  The TDRC prospectively agreed to serve as an external collaborator to support 
the research (See Appendix I). 
Minimal risk was present for participants.  The only risks from participation in the 
study were those involved with travel back to the clinic to return the electronic pillbox.  A 
return trip to the clinic for a post-treatment reevaluation is already one aspect of the current 
standard of care, though compliance is rare.  All other risks - physical, psychological, social, 
legal and economic - were minimal in probability, magnitude and duration. 
Confidentiality can also be a concern in studies involving human subjects.  The SMS 
interventions in this study did not jeopardize confidentiality since the SMS intervention did 
not address the individual by name, nor did it include any information about the patient.  In 
addition, malaria carries no stigma in Zambia.   Within the Zambian culture, illness and 
medicine are treated very differently than in western world.  There is some stigma associated 
with leprosy and sexually transmitted diseases, but with the clinic being a communal place, 
where gathering neighbors discuss their illnesses, and with malaria being extremely common, 
this diagnosis does not necessitate confidentiality (J. J. Enright, personal communication, 
June 23, 2014). 
The collection of data was communicated from the assistant directly to the PI, who 
entered the information by patient number rather than name on a secure, password-protected 
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computer accessible only to the PI.  Numbers were generally assigned in the order in which 
they presented to the clinic.  Paper documents that link the name and the patient’s number 
were stored in a locked file cabinet in the PI’s secure house.  The paper documents were 
destroyed at the conclusion of the presentation of the study findings.  Data will be stored 
indefinitely but without patient identifiers.  The PI will not use names or other patient 
identifiers when communicating data or results.  The SMS intervention did not address the 
individual by name nor did it include any information about the patient.   
There were no study-related costs to participants, and all costs for the electronic 
pillbox product were borne by the investigator.  No transportation costs were required from 
the patients since the primary method of access to the clinic is by foot.  There was a small 
risk that participants involved in the study could have been bothered by the SMS reminders.  
Benefits to Human Subjects 
Potential benefits to the individual participants included a higher likelihood of 
adherence and therefore more successful treatment for malaria.  The possible benefits to the 
community from a decrease in resistance are substantial and public policy could potentially 
be impacted.  In addition, the phone card offered in appreciation for participation benefitted 
those in the study. 
Intervention 
 The intervention used was a series of SMS messages in English (see Appendix A) 
sent directly to the participant by the PI at the times that the regimen prescribed the malaria 
medication was to be taken.  These SMS messages were to remind and encourage them to 
take their medication at that time.  The content of the messages varied slightly, but each 
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addressed the taking of the medication and, when the last dose was due, the SMS stated that it 
was the last dose.  
Instruments 
 The ParaHIT f RDT used in this research was manufactured by Span Diagnostics Ltd. 
WHO recommends a minimum standard of 95% sensitivity and 95% specificity for P. 
falciparum densities of 100/μl (WHO, 2006b).   Independent research evaluating this RDT 
resulted in a 97.6% (95% CI [95.6, 98.8]) sensitivity and 87.7% [83.0, 90.6] specificity, and 
concluded that it performed well, was appropriate for field use and can contribute to effective 
diagnosis of malaria (Guthmann et al., 2002).  The manufacturer’s literature indicates a 
sensitivity of 99.42% [98.3, 100] and a specificity of 99.59% [99.2, 100] (Span Diagnostics 
Ltd., 2013).  Differences in results may be attributed to improvements in the RDT in recent 
years.  A study of the average 2012 weighted cost for RDTs in Zambia was $0.31 (USAID 
Deliver Project, 2012).   Since RDTs are provided free of charge to government clinics in 
Zambia, there was no cost in the current study for the diagnostic tools. 
Although the PI’s and the participants’ phones were used to communicate via SMS, 
the only new instrument that was introduced into the study that was not standard care was the 
MEMS.   As discussed in the literature review and despite the limitations, the MEMS is 
considered the imperfect gold standard in pharmacoadherence measurement where direct 
observation is not feasible. 
Procedures 
Research Assistant 
The PI selected and hired a female research assistant after significant screening of 
potential applicants.  Qualifications included the completion of high school and fluency in 
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Bemba, the local language, and English, the national language.  The assistant was trained to 
interview potential participants, collect demographic data and educate the patient regarding 
the medication regimen.  She also completed Collaborative Institutional Training Initiative 
(CITI) Training as required by the University of Central Florida under the supervision of the 
PI. 
Recruitment 
The clinic nurse identified a potential participant through observational use of 
inclusion criteria, and referred him or her to the assistant.  The assistant then established the 
eligibility of the individual as a participant using inclusion/exclusion criteria, described 
details of participation, including the voluntary nature of the study and the incentive offered, 
and inquired regarding their willingness to participate.  If the individual was willing to take 
part in the study, the assistant obtained permission to record the conversation, educated the 
participant regarding the regimen, and obtained consent through signature on an Invitation to 
Participate which was printed in English (see Appendix B).  Information sessions were 
conducted in English, the national language of Zambia.  Participants received a copy of the 
study information form for their records.  The assistant’s interaction with patients was audio-
recorded, transcribed and randomly assessed for fidelity.  These recordings were destroyed 
upon completion of transcription and aggregation. 
Demographics and End-of-Study Questionnaire 
After consent was obtained, the assistant collected baseline demographic data and 
illness characteristics using a questionnaire (see Appendix C) designed for this study, which 
included demographic variables that were found in the literature review to be associated with 
adherence.  The demographic questionnaires had the patients’ names removed when they 
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returned the electronic pillbox for human subject protection.  All participants were asked a 
question as part of the end-of-study questionnaire when they returned the electronic pillbox 
that addressed the awareness of the existence of the other group in order to analyze for the 
possible effect of contamination. 
Pilot Study 
The first ten patients recruited comprised a pilot study to determine whether 
adjustments to the study were needed and to refine procedures before completing the study.  
The pilot included analysis of the use of the electronic pillbox and a determination of which 
SMS messages were most appreciated through an end-of-study questionnaire.  Adjustments 
were made as necessary, and those in the pilot study who needed no adjustments are included 
in the full and final sample.   
Random Assignment 
Each participant was randomly assigned to either the intervention group or the control 
group by block randomization through an envelope system.  
Participant Instructions 
The research assistant verbally instructed all participants on the treatment regimen.  
Patients were educated regarding the need to take medication with food, and, if vomiting 
occurs within one hour of the ingestion, to take the next dose and obtain a replacement dose 
from the clinic.  The healthcare provider administered the first dose of the medication in the 
clinic with the research assistant observing.   The assistant reviewed pictorial instructions and 
provided the remaining nurse-prepared medications per clinic protocol in perforated foil 
blister packs containing a 4-pill dose each.  These were inserted into an electronic pill bottle 
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with a MEMS cap (see Appendix D), along with written instructions regarding the regimen.  
The MEMS cap on the pillbox containing the ACT electronically recorded the time of each 
opening of the medication bottle beginning with the first dose.  The participant was instructed 
to return between three days and one week from the distribution date with the electronic 
pillbox for a health re-evaluation.  A pre-paid phone card with 20 kwacha (approximately 
$3.50) of talk time was presented in appreciation for participation when the bottle was 
returned.   
If the participant was in the control group, the assistant released him/her.  If the 
participant was in the intervention group, the SMS communication was described and 
reviewed if necessary.  The assistant then released him/her and initiated the SMS intervention 
sequence.    
SMS Intervention Sequence 
The PI generated an SMS reminder to the participant at the prescribed time each dose 
of the medication was to be taken - 8 hours after the initial dose and at the prescribed times of 
8 a.m. and 8 p.m. for the subsequent 2 days of the regimen (see Appendix A).  
Conclusion of Participation 
 When the participant returned the electronic pillbox, the data were transferred to a 
designated, secure computer and entered into IBM Statistical Package For The Social 
Sciences (SPSS) for review and analysis.  If the bottle was not returned within one week, an 
SMS reminder to return the bottle was sent.   If the bottle was not returned within the 
following three days, the assistant followed up with a community visit to collect the bottle 
and assess the patient’s health.  The participant was offered a Debriefing Statement following 
the return of the MEMS (see Appendix E). 
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Pharmacoadherence Measurement 
Pharmacoadherence was measured by comparing electronic pillbox openings to the 
prescribed times of the treatment regimen.  Adherence was defined as having an 
electronically recorded bottle opening within one hour of the prescribed time for the second 
dose (8 hours after initial dose), and a recorded bottle opening within two hours of the 
prescribed time for the next two days’ doses (8 a.m. and 8 p.m. on each day) based on dosage 
recommendations (Lefevre et al., 2001; WHO, 2012).  The completion of the regimen was 
verified by a final pill count (target = 0).  If the recorded bottle opening times fell within the 
designated ranges and the pill count was 0, the patient was considered probably adherent.  If 
either requirement is not satisfied, they were classified probably non-adherent.  
Statistical Analysis 
Once all data were collected and summarized, the data were screened for 
completeness.  The PI compared the proportion of those determined to be probably adherent 
in each group to those determined to be probably non-adherent, and a Pearson Chi-square 
test of independence was conducted to determine association between SMS reminders and 
pharmacoadherence.  In addition a Chi-square test of homogeneity was conducted to ensure 
uniformity of the two groups.  Finally, binary logistic regression was used to control for all 
demographic covariates and determine any factors associated with adherence. 
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Figure 4: Experimental Methods  
Assessed for eligibility from Fisenge Clinic 
• Adult (≥18 yrs) 
• Have cell phone available/SMS capability 
• Able to read three health-related phrases 
• Confirmed malaria (RDT) 
 
Target Enrollment n=88 
(Assuming attrition of 
25%, target at n=126) 
Exclusion criteria 
• Not meeting inclusion 
criteria 
• Recorded fever > 1 day 
prior 
• Malaria treatment in past 
2 weeks 
• Household member 
already participating 
Enrollment 
 Details of 
participation given 
 Incentive explained 
 Consent obtained 
 Demographic data 
collected 
 
Block Randomization 
Allocation through  
envelope selection system 
Data Collection & Analysis 
 Pillboxes returned within 3 days-1 week or follow-up initiated 
 Data on pharmacoadherence uploaded 
 Data screened for completeness 
 Data analyzed for association between SMS and pharmacoadherence 
 Logistic regression to control for contamination and other association 
 
Allocated to control 
group 
 Standard of Care + 
Electronic Pillbox 
 Patient released 
 
Allocated to intervention 
group (SMS) 
 SMS described & ability 
assessed 
 Mobile phone info & 
regimen entered into PI’s 
mobile phone for 
reminders to be sent (8 
hrs after initial dose + 8 
a.m. and 8 p.m. for 
remaining 2 days) 
 Patient released 
Education 
 Permission to audio record 
 Instruction on regimen/pillbox 
 First dose administered  
 Electronic pillbox with medication distributed 
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Figure 5: Consort Flow Diagram  
Assessed for eligibility (n=155) 
Excluded  (n=42) 
 Not meeting inclusion 
criteria (n=39) 
 Declined to participate 
(n=3) 
Analysed  (n=48) 
Excluded from analysis (n=9) 
 Conflicting instructions (n=4) 
 Malfunctioning MEMS cap (n=1) 
 MEMS caps not returned (n=4) 
Allocated to intervention (n=58) 
 Received allocated intervention 
(n=57) 
 Did not receive allocated 
intervention because malaria 
became complicated (n=1) 
Allocated to control (n=55) 
 Normal control group (n=54) 
 Malaria became complicated 
(n=1) 
 
Analysed  (n=48) 
Excluded from analysis (n=6) 
 Malfunctioning MEMS cap (n=2) 
 MEMS caps not returned (n=4) 
 
Allocation 
Analysis 
Randomized 
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Summary 
 In summary, this chapter reviews the methods used in this study including the design, 
sample and setting, ethical considerations, procedures and statistical analysis.  The methods 
reviewed are considered appropriate and feasible for the current study to determine the 
association between SMS reminders and pharmacoadherence.   
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CHAPTER FOUR: RESULTS 
MEMS cap and demographic data were collected over a 2-month period and analyzed 
using IBM SPSS for Mac version 22.0.  All records used in the sample were complete with 
no missing data.   
Characteristics of the Study Population 
 The study population consisted of those who met inclusion/exclusion criteria at 
Fisenge clinic from February 21 through April 26, 2014.  Though the targeted sample size 
was 126, data collection was stopped at 113 as more than 88 (target sample size) were able to 
be included in the analysis.  Of these, three were excluded because of malfunctioning MEMS 
caps; two because their malaria became complicated and they transitioned to alternative 
treatment; four because of conflicting medication instructions between the clinic staff and 
research assistant; and eight because the assistant was unable to collect the MEMS cap.  The 
remaining 96 (85%) consented to participate, were randomized to the control or intervention 
group, and their data were analyzed. 
 Among participants, 52.1% (n=50) were males and 47.9% (n=46) were females.   The 
participants ranged in age from 18-64 with 32.3% (n=31) of the sample aged 18-25; 28.1% 
(n=27) aged 26-35; 24.0% (n=23) aged 36-50; and 15.6% (n=15) over 50.  A large number of 
these were unemployed (61.5%, n=59) and/or had income less than 500 Kwacha rebased 
(Kr)/month (USD $75) (75%, n=72).  Additional demographic information is presented in 
Table 4.   
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Table 4: Summary of Demographic Characteristics 
Variable Response # (%) 
Age 18-25 
26-35 
36-50 
Over 50 
 
31 (32.3%) 
27 (28.1%) 
23 (24.0%) 
15 (15.6%) 
Gender Male 
Female 
 
50 (52.1%) 
46 (47.9%) 
Residence Village 
Rural 
 
65 (67.7%) 
31 (32.3%) 
 
Family income 0-100 Kr 
100-500 Kr 
500-1000 Kr 
> 1000 Kr 
 
63 (65.6%) 
9 (9.4%) 
17 (17.7%) 
7 (7.3%) 
Employed Yes 
No 
 
37 (38.5%) 
59 (61.5%) 
Own radio Yes 
No 
 
69 (71.9%) 
27 (28.1%) 
 
Languages able to write English 
English and Bemba 
English and Other 
English, Bemba and Other 
Bemba 
6 (6.3%) 
53 (55.2%) 
5 (5.2%) 
29 (30.2%) 
3 (3.1%) 
 
Languages able to read English 
English and Bemba 
English and Other 
English, Bemba and Other 
Bemba 
 
5 (5.2%) 
57 (59.4%) 
5 (5.2%) 
29 (30.2%) 
0 (0%) 
Highest grade completed 1-7 
8-9 
10-12 
College 
22 (22.9%) 
31 (32.3%) 
32 (33.3%) 
11 (11.5%) 
 
Taken malaria med before Yes 
No 
 
87 (90.6%) 
9 (9.4%) 
Belief in traditional tx  
(i.e. without medication) 
Yes 
No 
 
4 (4.2%) 
92 (95.8%) 
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Groups 
 Of the total sample (N=96), block randomization resulted in 50% (n=48) assigned to 
the control group and 50% (n=48) to the intervention group.  After reviewing the data, some 
variables (age, income, education) were collapsed to increase the n for analysis, and a Chi-
square test of homogeneity conducted.  Where the Chi-square assumption was not met, the 
Phi value was used.  The analysis verified that the randomization successfully achieved 
balance across observable characteristics with the two groups not differing significantly in 
any categories (p>0.05) (see Table 5). 
Table 5: Chi square test of homogeneity 
 
Variable 
 
Response 
Intervention  
Group 
Control 
Group 
 
p value 
Age 18-35 
Over 35 
 
31 (64.6%) 
17 (35.4%) 
27 (56.3%) 
21 (43.8%) 
.404 
Gender Male 
Female 
 
21 (43.8%) 
27 (56.3%) 
29 (60.4%) 
19 (39.6%) 
.102 
Residence Village 
Rural 
 
30(62.5%) 
18 (37.5%) 
 
35 (72.9%) 
13 (27.1%) 
.275 
Family income 0-500 Kr 
> 500 Kr 
 
36 (75.0%) 
12 (25.0%) 
36 (75.0%) 
12 (25.0%) 
1.00 
Employed Yes 
No 
 
16 (33.3%) 
32 (66.6%) 
21 (43.8%) 
27 (56.3%) 
.294 
Own radio Yes 
No 
 
31 (64.6%) 
17 (35.4%) 
38 (79.2%) 
10 (20.8%) 
.112 
Highest grade 
completed 
1-9 
10-College 
 
26 (54.2%) 
22 (45.8%) 
27 (56.3%) 
21 (43.8%) 
.837 
Taken malaria med 
before 
Yes 
No 
 
43 (89.6%) 
5 (10.4%) 
44 (91.7%) 
4 (8.3%) 
.726 
Belief in 
traditional tx  
(i.e. without 
medication) 
Yes 
No 
 
2 (4.2%) 
46 (95.8%) 
2 (4.2%) 
46 (95.8%) 
1.00 
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Findings 
Pilot Study 
Only one adjustment was made following the pilot study.  The PI discovered that the 
clinic nurse was prescribing second and third day dosages at 6 a.m. and 6 p.m., and the SMS 
reminders were being sent at 8 a.m. and 8 p.m. as initially planned.  This caused some 
confusion in the intervention group resulting in the exclusion of 4 patients from the final 
results.  After consultation with the clinic nurse and the research assistant, the determination 
was made that the clinic nurse would prescribe the 8 a.m. and 8 p.m. schedule to coincide 
with the SMS reminder.   
Adherence 
Only two participants did not complete the regimen resulting in exclusion from the 
study.  Pill counts revealed only one dose left in the returned bottles, which was from a 
patient’s case that was redefined as complicated and excluded.  All other pill counts were 0 
(zero) as required for the category probably adherent. 
No significant association was found between SMS reminders and 
pharmacoadherence among malaria patients being treated with ACT when evaluated with 
respect to those who received the SMS reminders and those who did not (χ2=0.19, df=1, 
p=0.67).  Findings indicated that 64.6% (n=31) of those in the intervention group were 
probably adherent compared with 68.8% (n=33) of those in the control group (see Table 6).   
Of the total, 66.7% (n=64) were classified as probably adherent and 33.3% (n=32) as 
probably non-adherent.  Of those identified as probably adherent, 51.5% (n=33) were male 
and 48.5% (n=31) were female.  
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Table 6: Adherence Results 
 
Twenty participants had probable perfect adherence as defined by digitally-recorded 
MEMS bottle openings occurring only during the timeframes of adherence and only the 
required six openings with one in each timeframe.  Of those, 12 (66.7%) were in the 
intervention group and 8 (33.3%) in the control group indicating that the SMS intervention 
may have been helpful for staying within the prescribed parameters.  However, when these 
data were analyzed by Pearson’s Chi-square test of association, the result was still not found 
to be significant (χ2=1.01, df=1, p=0.32).  Though underpowered, these data may provide 
direction for further research.  
Table 7: Probable Perfect Adherence Results 
 
Binary logistic regression was used to determine if any other independent variables 
(town, age, gender, belief in traditional treatment, prior treatment, fever time, education, 
employment status, family income and radio) were associated with adherence.  The variables 
 Intervention (SMS) 
# (% of group) 
Control (No SMS) 
# (%) 
Total 
# (%) 
Probably Adherent 
 
31 (64.6%) 33 (68.8%) 64 (66.7%) 
Probably 
non-Adherent 
17 (35.4%) 15 (31.2%) 32 (33.3%) 
Total 48 48 96 
 Intervention (SMS) 
# (% of group) 
Control (No SMS) 
# (%) 
Total 
# (%) 
Probably Perfectly 
Adherent 
 
12 (25%) 8 (16.7%) 20 (20.8%) 
Probably Not  
Perfectly Adherent 
36 (75%) 40 (83.3%) 76 (79.2%) 
Total 48 48 96 
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languages read and languages written were excluded due to small sample sizes in some 
groups resulting in widely varying, insignificant statistical results.  To increase statistical 
power and simplify interpretations the following variables were collapsed into binary 
variables for the logistic regression: age, education, family income, fever time.  A forward 
step-wise procedure was then executed.  Analysis indicated that there were no variables 
associated with adherence (see Table 8) (p<0.05). 
Initial binary logistic data were screened and regression results indicated that the 
overall model fit was questionable (-2 Log likelihood = 115.9) and was not statistically 
significant in distinguishing between groups (χ2 = 6.31; df = 10; p = 0.79).  The model 
correctly classified 64.6% of the cases, a decrease of 2.1% compared to the model without 
the independent variables considered (66.7%).  Regression coefficients are presented in Table 
8.  Both the Wald statistics and the odds ratios indicate little change in the likelihood of 
adherence based on the SMS intervention. 
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Table 8: Binary Logistic Regression of Variables 
 B Wald df OR 95% CI p 
Town       
   Village    1.0 (ref)   
    Rural 
 
-0.55 1.0 1 0.58 0.20, 1.7 0.31 
Age       
     18-35 yrs    1.0 (ref)   
     >35 yrs 
 
-0.72 2.1 1 0.49 0.19, 1.30 0.14 
Gender       
     Male    1.0 (ref)   
     Female 
 
-0.28 0.27 1 0.76 0.26, 2.2 0.61 
Traditional 
belief 
      
     Yes    1.0 (ref)   
     No 
 
0.63 0.26 1 1.9 0.17, 21.2 0.61 
Prior tx       
     Yes    1.0 (ref)   
     No 
 
-0.28 0.12 1 0.76 0.16, 3.6 0.73 
Reported 
fever time 
      
     <24 hrs    1.0 (ref)   
     >24 hrs 
 
-0.33 0.47 1 0.72 0.28, 1.9 0.49 
Education       
     Gr 1-9    1.0 (ref)   
     > Gr 9 
 
-0.65 1.6 1 0.52 0.19, 1.4 0.20 
Employed       
     Yes    1.0 (ref)   
     No 
 
-0.21 0.087 1 0.81 0.20, 3.2 0.77 
Family 
income 
      
     0-500 Kr    1.0 (ref)   
     >500 Kr 
 
-0.38 0.21 1 0.68 0.13, 3.5 0.64 
Own radio       
     Yes    1.0 (ref)   
     No -0.59 1.10 1 0.56 0.19, 1.7 0.30 
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However when binary logistic regression was run using the same variables against 
probable perfect adherence, three factors were significant:  Lower age (OR 0.099, 95% CI 
[0.024, 0.41], p<0.01), owning a radio (OR 0.096, [0.019, 0.47], p<0.01), and residing in a 
village rather than rural (OR 0.116, [0.026, 0.51], p<0.01).   
In addition, the Omnibus Test of Model Coefficients resulted in χ 2=27.04 (df=1, 
p<0.01).  Results indicated that the overall model fit using probable perfect adherence was 
better than the fit using probable adherence (-2 Log likelihood = 71.2).  The model correctly 
classified 85.4% of the cases, an increase of 6.2% compared to the model without the 
independent variables considered (79.2%). 
In addition, the mean number of bottle openings for the sample (N=96) was 7.8 for a 
regimen that only required six openings.  The number of openings ranged from 5 to 15 with 
the majority of the participants opening the bottle more than the necessary 6 times.   
End of Study Questionnaire 
The results of 24 self-report end-of-study questionnaires (see Table 9 & Appendix J) 
provide data for possible further research.  Responses to the question regarding awareness of 
a second group indicated that there was no awareness so contamination is not suspected.  
When asked what aspect of the regimen was most helpful for taking the medication, results 
were mixed, but 20 of the 24 (83.3%) included SMS as being one of the most helpful 
components.   
 Regarding the helpfulness of the timing of the SMS the 25% who indicated that the 
evening reminders seemed most helpful suggested that it was because of the many 
distractions that they faced during that time of day.  One participant mentioned that both were 
helpful “because they were encouraging me showing that they care for my health.”  
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 The final question was to gauge whether participants viewed ACT as a primary or a 
secondary approach to treatment.  When asked if they sought help prior to coming to the 
clinic, only two respondents replied that they had tried alternative treatment.  Results 
indicated that seeking medical treatment from a professional healthcare provider seems to be 
the primary choice of most of those (92%) presenting to the clinic.  Further qualitative studies 
are necessary to determine true predictors of and factors affecting adherence. 
Table 9: End of Study Questionnaire Results 
Question Responses 
# (%) 
  
What was most helpful in taking the medication?    
     Pill bottle 0 (0%)   
     SMS reminder 8 (33.3%)   
     Packaging (blister pack) 2 (8.3%)   
     SMS & packaging 2 (8.3%)   
     SMS & pill bottle  2 (8.3%)   
     Pill bottle & packaging 2 (8.3%)   
     Combination of SMS, pill bottle & packaging 8 (33.3%)   
Which SMS messages were most helpful for reminders?    
     Morning reminder 3 (12.5%)   
     Evening reminder 6 (25.0%)   
     Both equally helpful 11 (45.8%)   
     No response 4 (16.7%)   
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CHAPTER FIVE: DISCUSSION 
Literature Review and Theoretical Framework 
 P. falciparum malaria-associated infection continues to burden individuals and public 
health services in sub-Saharan Africa in the areas of health, longevity and economics.  
Despite having the best medication available to treat an illness, pharmacoadherence remains 
an integral key to effective treatment.   
While the association between the SMS and adherence were not significant, the rates 
of adherence for both control (68.8%) and intervention groups (64.6%) were higher than 
other comparable measures of ACT adherence in sub-Saharan Africa.  Best practice methods, 
such as the pictorial instruction, were intentionally implemented in this study to maximize 
adherence rates and may have contributed to the higher level of adherence.  The Hawthorne 
effect may also have led to the higher rates.  When the definition of adherence included 
consideration of the medication timing in the literature, probable adherence ranged from 
38.7% (Lemma et al., 2011) to 48.3% (Gerstl et al., 2010).  It was only when factors such as 
timing were removed that rates of ACT adherence in other studies fell in a similar range to 
the current study (Cohen et al., 2012; Lawford et al., 2011).  The higher rate of adherence 
may be attributed to the use of the MEMS bottle, which has been found to improve adherence 
(Fallab-Stubi et al., 1998; Kahook, 2007).   The additional attention given to the patients in 
the research might also contribute, though no base-line adherence rates are available for 
patients in the Copperbelt Province of Zambia. 
Though the literature review indicated an association between SMS and adherence, 
the current study’s data indicated no such association.  Most studies measuring SMS direct to 
patients and indicating association were conducted with ART adherence, but since ACT 
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adherence is a short-term regimen, results were expected to be similar or better (Horvath et 
al., 2012; Kunutsor et al., 2010; Lester et al., 2010; Pop-Eleches et al., 2011).   
The reasons for lack of association between SMS and ACT adherence in the current 
study may be difficult to discover.  SMS may provide simply another tool in the 
comprehensive, multi-pronged approach that must be tailored to local contexts (Chi & 
Stringer, 2010).  The current study certainly reinforces the ease of implementation and 
technical feasibility suggested by others regarding the use of the mobile phone for adherence 
in resource-limited settings (Crankshaw et al., 2010; Haberer & Kiwanuda, 2010; Kamanga 
et al., 2010).  However, the lack of research using mobile phones for malaria leaves little 
material with which to compare (Kaplan, 2006; Zurovac et al., 2012). 
When using the probable perfect adherence in logistic regression, several of the 
factors identified in the literature review were also found to be significant in this study.  The 
three variables, lower age, owning radio, and living in a village were associated with 
increased rates of probable perfect adherence across all study participants.  The lower age 
may be associated due to the young being more open to treatment by medication since they 
did not live through much of the traditional treatment history that preceded modernity.  
Owning a radio may indicate a higher socio-economic status and/or being exposed to mass 
media anti-malarial campaigns.  Village life would bring more exposure to the experience of 
others who have benefited from medical treatment compared to those living in rural areas.  
The likelihood of electricity in the village also brings an added level of technology, and with 
it, education. 
 The use of the TPB, while helpful, proved problematic to measure as a cognitive 
model.  It is difficult to determine if the SMS intervention was successful in improving 
intention to adhere, one aspect of perceived behavioral control in the TPB.  Intention to 
adhere was assumed in this study, and the measurement of this research targeted adherence 
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behavior rather than intention.  Several individuals responded to the SMS with appreciative 
SMS return responses for the attention and care offered.  One responded, “Thanks for your 
encouragment, i even went for work. May God bless you gudnite [sic].” Another, “yes im 
[sic] feeling better now thank you.”  And another, “Thank you very much.  I have taken it im 
[sic] better now.”  Anecdotally, many patients responded positively to the SMS reminders as 
the literature suggests (Dean et al., 2012; DeRenzi et al., 2012; Donald et al., 2007; Hoffman 
et al., 2009; Jones et al., 2012).   
The potential barriers identified in the application of the TPB to pharmacoadherence 
that prevent the planned behavior (i.e. taking prescribed medication according to regimen) 
from becoming actual behavior were forgetfulness, bad taste, negative side effects and 
subsiding symptoms.  Though the use of the SMS reminder intervention addressed primarily 
the forgetfulness aspect, it did not address and overcome any barriers to actual control that 
resulted in improved pharmacoadherence behavior.  The reasons for that failure are not 
readily apparent although multiple challenges existed that may have contributed to the poor 
association. 
Evaluation of Design 
Introduction 
Every study is only as good as the integrity of its design.  One must consider multiple 
factors that affect both internal and external validity and how they might have influenced the 
study.  
Internal Validity 
Multiple factors threatened the internal validity, and the design incorporated measures 
to address some of these threats.  Randomization, homogeneity and standardization helped to 
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create a balanced design.  One of the primary threats in any experiment is that factors other 
than the intervention may contribute to the measured difference, and therefore must be 
considered.  Randomization was used to assign participants into either the intervention or 
control group, and both groups contained an equal number of subjects from the same village.  
Demographic logistical analysis was performed to ensure homogeneity, which was verified 
through the Chi-square test of homogeneity.  Thorough training of the assistant and scripting 
of the educational material standardized the interaction with both the intervention and the 
control group.  The script was also worded in such a way as to attempt to eliminate 
experimenter bias or undue influence by being reviewed by a local consultant prior to 
implementation.  To avoid the possibility of being perceived as coercive, the PI provided 
vigilant monitoring through a systematic review of random audio recordings of the assistant’s 
interactions with participants that better assured adherence to standardization.  The PI found 
no significant variations from the script.  Applying the measures described mitigated the 
identified threats to internal validity. 
In addition, valid statistical analysis requires an adequate sample size.  The target 
sample size (N=88) in this study was determined with G*Power software and was exceeded 
with a sample size of 96.  There are no identified significant threats to internal validity in this 
study. 
External Validity 
Additional measures were critical to ensure external validity allowing generalizability 
to the population of interest.   A representative sample design was one necessary measure 
implemented to enhance external validity.  While the convenience sample used in this design 
was a nonprobability sample, the prevalence of malaria occurrence and the homogeneity of 
the village help enhance generalizability.   
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 The Hawthorne effect, novelty effects and experimenter effects may limit 
generalizability (Polit & Beck, 2004).  The Hawthorne effect describes the behavior that may 
result because the participants know that they are in a study, and therefore behave differently 
than if they are not.  This effect was impossible to avoid given the use of the MEMS bottle 
and the notification requirements of the IRB.  Expectancy effects may be motivated by a 
desire to please the assistant, by being adherent, or by some incentive perceived or actual.  
According to the clinic staff, the study participants displayed a much higher rate of return to 
the clinic post-treatment than non-participants thus enabling follow-up and further health 
assessment. The phone card incentive that was offered to all participants in both groups for 
returning the MEMS caps and bottle provides a probable explanation for the increased rate of 
return. 
The novelty effect refers to the effect that the relatively new technology of SMS 
and/or the electronic pillbox, might have on patient adherence incentive.  Though novelty 
effects can limit external validity, they are extremely difficult to address and to quantify.  
However, the advantage of the version of the MEMS cap used in this study is that it is not 
overtly technological.   The appearance is similar to a standardized pill bottle somewhat 
limiting the novelty effect. 
Experimenter effects operating in the assistant and the PI may also introduce some 
bias.  The intellectual and/or emotional investment of desiring an intervention to be 
successful could lead to misinterpretation or subconscious guiding of the patients.  The PI as 
a white Westerner in an African culture avoided direct contact with the Zambian clients in 
order to minimize experimenter effects.  Careful training of the assistant, script writing, 
recording, and systematic monitoring of compliance to the script also helped to minimize 
these concerns. 
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Methodological Assumptions and Limitations 
 Methodological assumptions and limitations in this study fall into the categories of 
design, sampling, measurement, statistical analysis and other challenges. 
Design 
One study limitation was the possibility of contamination.  While participants were 
masked to the intervention, both experimental and control groups reside in the same highly 
social community; therefore, information regarding the group differences was investigated to 
determine significance.  Since none of those responding to the end-of-study questionnaire 
indicated knowledge of the other group, contamination was considered negligible.   
A further limitation of the study was that receipt and timing of SMS messages were 
not confirmed due to the lack of availability of read receipts for SMS in Zambia.  The 
participants’ phones were not reviewed to determine if and when the messages that were sent 
were, in fact, received and read.  Of course, even if read, there is no means of determining 
whether the intended participant read them, a reasonable concern recognizing the shared 
nature of cell phones in low-resource settings.   
Other issues that could negatively impact the timeliness of the receipt of the SMS 
include participants leaving the coverage area, not being in the vicinity of their phone, or 
having depleted mobile phone batteries without immediate access to electricity to recharge 
them.   
Sampling 
Using a convenience sample as opposed to a probability sample can result in selection 
bias (Oleckno, 2002).  Due to the sampling being taken from a single village location, patient 
demographic characteristics may differ from those in other regions of the country.  Those 
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who participated and/or those who qualified to participate may possibly have differed 
demographically from those who did not.  Those who did not qualify were not asked to 
complete a demographic questionnaire largely due to linguistic and literacy challenges.  
Future studies could implement this process in order to better explore generalizability.  While 
all visible observations indicate that Fisenge is a typical rural Zambian village in the 
Copperbelt Province, clinic and village statistics were not available to justify this assumption, 
limiting generalizability without further statistical substantiation. 
Measurement 
The study presents several measurement challenges.  The largest challenge to 
accuracy and precision comes with defining and measuring actual adherence.  If a patient 
consumes the medication within one hour of the prescribed time, is he/she adherent?  Are 
participants adherent if within two or three hours?  Precision in measuring adherence proves 
problematic without clearly defined adherence parameters.  The measurement parameters 
chosen herein are based on an exploration of adherence definitions in malaria research 
literature and a strict definition was selected for conservative purposes (Lefevre et al., 2001; 
WHO, 2012).   
DOT best assures actual adherence to a prescribed regimen, but multi-day regimens 
with outpatients render such assurance difficult at best.  Electronic monitoring such as the 
MEMS cap helps, but it records only the opening and closing of the pill bottle, not ingestion 
of medication.  The participants may also save or give away the medication resulting in a 
false indication of adherence.   The best assurance and most precise description of adherence 
that a researcher is able to achieve given these limits is probable adherence.   
In this research, the assumption was that if a MEMS cap recorded an opening during 
the adherence time window probable adherence was assumed, even if the bottle was opened 
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at other times between adherence windows.  The excessive number of bottle openings may be 
due to the novelty of a new dispenser since most medication from the clinic is dispensed in 
small, clear, plastic medication bags with zip seals.  Both groups were using the same type of 
electronic pillbox and the same standard of adherence, so the precision of the measurement of 
actual adherence was less critical in this study than the consistency of measurement between 
groups in order to ensure comparability and to validate the use of the Chi-square statistic.  
The small number of those identified as probably perfectly adherent verifies the difficulty in 
determining adherence even with the MEMS cap.   
Another factor limiting the measurement of adherence in this study is the 
dichotomous nature of adherence chosen in this design when assigning participants to either 
probably adherent or probably non-adherent.  There is no measurement of partial adherence 
or analysis of different aspects of adherence like the specifics of timing or number of pills 
taken other than an end of study pill count.  Consistency in the definition and measurement of 
adherence is critical as related studies are conducted. 
Statistical Analysis 
 One assumption of the Chi-square test is that no cells have a count of five or less.  
Our analysis and sample size met that assumption, validating the use of Chi-square. 
Other Challenges 
 Every study faces challenges, but those conducted in low-resource settings, such as 
much of sub-Saharan Africa, face a unique set of challenges, each one an opportunity for 
further exploration.  Factors that influence pharmacoadherence in Zambia likely have a wide 
application to other sub-Saharan settings. 
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 One of the challenges in this study was the communication barrier between the PI and 
others involved in the research – the assistant, the clinic nurse and the patients.  Though the 
assistant was fluent in English, miscommunication still occurred.  The explanation of 
randomization, for example, took significant explaining multiple times before the assistant 
understood the process.  This communication barrier even with those fluent in English could 
potentially impact the study.  Recording the assistant’s interaction with participants served to 
mitigate that issue. 
Another significant communication challenge is the large number of languages 
spoken by the clinic’s patients.  There may be communication and information biases due to 
interpretation and translation issues, although such bias is most likely insignificant. 
 Cultural differences also proved to be challenging.  Generally members of the 
community have a clear understanding of the signs and symptoms of malaria and when to 
seek treatment.  However, beyond the signs and symptoms, there continues to be many 
misconceptions on the etiology of malaria.  For example, a significant number of community 
members reported that malaria can be contracted by eating an unripe mango, or even from 
being caught out in the rain.  Curses and spells are believed to be one of the primary causes 
of illness in the Copperbelt.   Based on these misunderstandings, it seems that better 
education and knowledge may improve not only adherence, but also prevention of the 
disease.  Though a greater percentage of those over grade nine (72.2%) were probably 
adherent than those under grade nine (62.2%), the difference was not significant (χ2=1.03, 
df=1, p=0.31).  An understanding of the importance of adherence to a treatment regimen and 
its link to the high rate of morbidity and mortality brought on by malaria is crucial to 
motivate adherence.   
Traditional African belief often attributes the causes of diseases to ancestors or 
witchcraft.  Two cases of superstition nearly caused the loss of data and MEMS caps.  In one 
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case, a patient related that her spouse encouraged her to throw the bottle down the outhouse 
because it must be witchcraft that is involved:  “Why else would they want to know how 
many times you opened the bottle?”  A second story indicated that the PI’s name (Elinda) 
was so closely related to the local river goddesses (Linda, Belinda, Brenda) that there must be 
witchcraft involved.  Fortunately in both cases, participants discussed the matter with the 
research assistant or clinic staff and returned their bottles.  In retrospect, the research 
intervention may have been more successful in an urban setting where education levels are 
higher, belief in western medicine is widespread, and English speaking is more prevalent.  
However, such a setting would also further limit generalizability to rural Zambians. 
Another concern is the status of the eight who did not return their MEMS caps.  It is 
possible that they were aware of their failure to adhere so retained the caps to prevent 
measurement.  However, since four were from the control group and four from the 
intervention group, any effect that would present would likely be distributed evenly between 
the groups. 
Some challenges involve the use of mobile phones.  The cost of mobile phones and 
the poverty in sub-Saharan Africa often lead to fixed shared-access mobile phones (Kalba. 
2008).  These mobile phones are shared among a fixed household or family, which 
complicates direct and timely communication to individuals.  Though the participant may still 
have access as required for this study, the phone may be in use by another member of the 
household at the time the SMS is sent.  Future studies should consider methods of confirming 
receipt of SMS reminders by the participant. 
In a country where various aspects of the mobile phone industry, such as network 
coverage, contribute to the use of multiple subscriber identification module (SIM) cards from 
multiple providers used by each individual, one challenge is knowing to which phone number 
the SMS is to be sent.  Although the assistant only asked for one phone number to which to 
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send the SMS, the PI would sometimes receive a response from the same participant using a 
different phone number than the one given.  This confusion may have led to missed messages 
if a different SIM card was installed in the shared-access phone at the time of the SMS.  
Alternative card use could be due to one SIM card being out of prepaid talk time or cheaper 
call rates within a specific network resulting in a different SIM card being installed.  
Another challenge was the need to reuse MEMS caps for multiple patients, a practice 
that is discouraged by the manufacturer, Aardex (2013).  The primary reason for the 
discouragement of this practice is the possibility of cross-contamination, however since 
malaria in a non-contagious disease, and because the pills were in blister packs within the 
bottles, this objection was not considered substantive.  While the multiple use of each bottle 
did not impede the research, the compilation of the data was slightly more complicated by the 
reuse of the MEMS caps.   
 The only economic challenge associated with long-term use of this SMS intervention 
with the MEMS caps is the expense, which at this time is cost-prohibitive in resource-limited 
settings.   A comprehensive cost analysis would need to be done for any large-scale 
applications of SMS reminders for adherence.  Such costs may include investments in 
computer equipment and salaries for administrative purposes.  However, the costs of all other 
aspects of the study, including the SMS (approximately USD $0.01/message or a total of less 
than $10 for all messages in the current study) and the ACT treatment proved negligible due 
in part to government supply of free ACT to all public clinics, indicating that the intervention 
is both actionable and practical for future research where similar conditions exist.   
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Implications for Nursing Practice and Policy  
Practice 
The study indicates few implications to nursing practice due to the lack of association 
between SMS and adherence other than to add to the current body of knowledge.  However, 
there are some implications for nursing research.  Pharmacoadherence is a multi-faceted 
concept that will not be easily solved with any individual intervention.  The SMS reminder, if 
found to be associated with adherence in further research, can be used to supplement other 
adherence strategies in the hope to improve pharmacoadherence not only for ACT and 
malaria, but also for other long-term illnesses, where forgetfulness may be more prevalent. 
The many challenges that the PI faced with communicating clearly to those of another 
language and culture reinforced the necessity of adequate training and understanding for 
those involved in research.  One is dealing with multiple layers of tradition and traditional 
understanding, which are not going to be replaced with a scientific understanding in a brief 
time of training.  The more one learns about the culture prior to research, the less likely 
miscommunication and misunderstanding is to occur.  Ideally the researcher would come 
from the same culture and speak the same language as those among whom the research is 
conducted.  This would minimize undue influence and misunderstanding or 
miscommunication.  However, the assistant used in the current study was the contact person 
by participants and shared both the same culture and the same language with them. 
The PI used best practice standards in the current study such as blister packs and both 
written and pictorial instructions.  The phone card incentive may also have motivated 
pharmacoadherence.  The lack of adherence differences discovered and the higher level of 
adherence may be due to a combination of these best practices and the incentive provided. 
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Sixty-two of the participants (65%) claimed that their fever began more than 24 hours 
prior to clinic arrival, however these were all self-report without thermometer verification.  
Though only two participants’ malaria became complicated, health education must address 
the need for earlier intervention for treatment initiation or clinic consultation in order to 
reduce the risk of severe malaria infection and mortality. 
Sub-Saharan Africa is in the early-majority stage of the technology adoption curve as 
determined by Kalba (2008) and defined by Rogers (2003).  As mobile phones become more 
prevalent and the coverage and use more sophisticated, these powerful tools will be able to be 
utilized in multiple ways to assist healthcare.   
Policy 
Global policy provides the needed framework to deliver effective healthcare services.  
The United Nations has established eight Millennial Development Goals, the sixth of which 
is to combat HIV/AIDS, malaria and other diseases.  The third part of this target goal is to 
halt and reverse the incidence of malaria by 2015 (UNF, 2012).  A significant global 
initiative, the RBM Partnership, was launched in 1998 bringing together the WHO, the 
United Nations Children’s Fund (UNICEF), the United Nations Development Programme 
(UNDP) and the World Bank in an effort to provide an effective and coordinated global 
response to malaria.  Today RBM embraces over 500 partners including malaria endemic 
countries (RBM, 2010). 
The National Malaria Control Programme of Zambia falls under the Directorate of 
Public Health and Research in the Ministry of Health and has established the Zambian 
National Health Strategic Plan 2011-2015 (MOH, 2011).  One of the main objectives of this 
plan is to reduce the annual incidence of malaria to 75 per 1,000 by 2015 exceeding the RBM 
goal (RBM, 2010).  Two strategies in the plan, a focus on health service delivery by 
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promoting support for health management, and targeting malaria treatment interventions offer 
opportunities for technology to be used to improve pharmacoadherence (MOH, 2011).  
However, any such use is affected by mobile network coverage and marginalized areas must 
be targeted by national policies to ensure the effectiveness of such interventions. 
The local policy strategy involves management of malaria in health facilities, 
communities and homes using ACT as a first-line drug to increase access to prompt malaria 
treatment.   A challenge to achieving this action point is that, at the provincial and district 
levels, there are limited human resources to coordinate treatment strategies, increasing the 
necessity for discovering methods by which to maximize effectiveness (RBM, 2010).  
Researchers are compelled to continue to explore technological interventions such as SMS to 
assist in this effort. 
Recommendations for Further Research 
 The additional data collected from the end-of-study questionnaire provides 
groundwork for further research related to pharmacoadherence.  In particular, the data 
provides a foundation for a follow-up qualitative study on the factors that may influence 
pharmacoadherence, as well as a study of the contextual traditional assumptions that impede 
adherence.  If some factors could be identified as being associated with non-adherence, 
research could target those related causes more effectively. 
While SMS reminders were not significantly associated with increased 
pharmacoadherence, addressing some of the other barriers may help overcome the human 
limitations of poor adherence.  Further research could investigate means of addressing these 
barriers through the use of mobile phones.  For example, using a voice call rather than SMS 
to contact the patient would allow dialogue, possibly enlightening the caregiver to other 
unidentified barriers.  Use of voice reminders as opposed to SMS could be explored to 
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determine if the social aspect of verbal communication enhances adherence.  However, such 
interventions also increase the time and financial costs involved. 
 Though the length of SMS has been addressed in some studies (Horvath et al., 2012) 
the content of the SMS messages is also an aspect that could benefit from further research.  
Perhaps the wording of the message could be improved or other elements added or the 
message sent in the local language.  Another possibility could explore an SMS response back 
from the participant with information on the time the medication was taken.   However, 
returned communication increases the cost to the patients as mobile phone charges are 
applied to the contacting party in Zambia. 
 A standardized 8 a.m. and 8 p.m. protocol of SMS messages was used for this study, 
however the exact timing of the SMS could be further tailored to the participant’s schedule.  
When a participant is diagnosed with malaria and offered the ACT, they could be asked what 
time in the morning and evening would be best for them to take the medication and schedule 
the SMS reminders accordingly.  Since the twelve-hour difference is somewhat flexible, they 
could , for example, take their morning dose at 7 a.m. and their evening dose at 8 p.m.  If 
automated software were used to initiate the SMS reminders, the additional work to 
customize the timing of the SMS messages to the lifestyle of the patient would be negligible. 
 One of the areas ripe for research in sub-Saharan Africa is the dependability of self-
report which is the primary method of measurement in many ACT pharmacoadherence 
studies (Cohen et al., 2012; Lemma et al., 2011; Onyango et al., 2012).  In a culture where 
the intention is to please and time schedules are not a priority, this method has little reliability 
(Lewis, 2006).   One study in Malawi comparing self-report to MEMS and pill count resulted 
in only 0.8% (n=3) admitting to missing doses on self-report.  However 9.4% (n=17) had 
remaining doses in their MEMS bottles when returned (Bell et al., 2009).  In addition, 
research measuring adherence indicated that MEMS results called into question the 100% 
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adherence made by SMS self-report (Haberer & Kiwanuda, 2010).  Further research is 
needed possibly using MEMS or virtual DOT to measure the reliability and validity of self-
report and to determine ways to more accurately measure actual pharmacoadherence. 
 MEMS caps offer a more reliable method of measuring/encouraging 
pharmacoadherence than self-report, however the cost of the caps renders them impractical 
for widespread use in sub-Saharan Africa and other low-resource settings.   
 While this study did not determine the satisfaction of the patients with the 
effectiveness of ACT treatment, further research could explore this area to determine if it is 
associated with a higher level of adherence. 
The MEMS data indicated that in several cases there were substantially more bottle 
openings than there were doses.  Further study could seek to determine the reasons for the 
multiple openings especially given that part of the briefing by the assistant included a request 
not to open the bottle except when taking medication.  Determining the reason for the extra 
openings may help identify methods to limit these and thus more accurately measure 
pharmacoadherence.  
Two life-long residents of Africa, one an American, born and raised in central Africa 
and the other an indigenous leader in the community describe the nature of paradigm shifts 
and obstacles to behavioral change in this context.  Because the culture of central Africa is 
very resistant to change, Rogers’ (2003) Diffusions of Innovations model warrants further 
exploration as a theoretical backdrop to research implementing new methodologies or 
modern technological tools.  Life in this culture has traditionally been fraught with danger 
from famine, war, disease and forced migration.  Those who were quick to embrace change 
often died because they gave up their traditional forms of protection and were no longer able 
to deal with the recurring African dangers.  Thinking in terms of inertia and momentum one 
might say that this culture exhibits a great deal of inertia where change is concerned and 
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health practices are no exception.  Clinics and hospitals see many patients in urban areas, but 
a large and mostly unidentified segment of the population continues to rely on traditional 
healing through charms, plants or combinations of both.  Many rural communities in Zambia 
have no access to western medicine so traditional cures are all that is available.  Gradually the 
tide has changed in urban areas and many people now come to clinics for treatment.  
Momentum seems to be starting to build in favor of western medicine as people experience 
and witness the effects.  The western medicinal approach to the treatment of malaria can be 
considered a whole new approach to medicine in sub-Saharan Africa and would naturally 
experience all the normal resistance that the culture exhibits towards innovation.  As the 
incorporation of this method into the normal treatment of malaria continues, the inertia might 
gradually be overcome and with it momentum might begin to move the culture towards 
accepting this new medical practice.  Once accepted, it would become the new status quo and 
adherence would be strongly motivated by the same cultural resistance to change that initially 
made it difficult (J. J. Enright & R. S. Kilembo, personal communication, April 5, 2014).   
Another method suggested by the Diffusion of Innovations model to speed up the 
acceptance of this healthcare model would be to actively recruit the traditional leaders and 
healers in the community to endorse and advocate this approach (Rogers, 2003).  Traditional 
chiefs’ power and authority is limited in urban areas in Zambia, but both are significant in 
rural areas.  A sustained endorsement by the chief and sub-chiefs might have a profound 
effect on the acceptance of this method.  Likewise, bringing the traditional healers in a 
community on board through dialogue and education would initiate a significant endorsement 
of the method.  Zambia is overwhelming Christian and bringing local pastors, ministers and 
priests on board would provide another way in which traditional figures of authority would 
lend their influence to bring about acceptance of this method (J. J. Enright & R. S. Kilembo, 
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personal communication, April 5, 2014).  Clearly, context and culture need to be seriously 
considered in any study design conducted by westerners in sub-Saharan Africa. 
Summary and Conclusion 
All study results from this research will be shared with the external collaborator, the 
Tropical Disease Research Centre, Ndola, Zambia, and with the Zambian Ministry of Health, 
and submitted for possible publication.  The aggregate results will also be made available to 
the participants at their request. 
Preventing malaria is the best strategy for reducing morbidity and mortality.  
However, once infected the value of ACT pharmacoadherence for treatment justifies 
continued attempts to improve the statistics in order to combat malaria in sub-Saharan Africa.  
Though the results of the current study did not find a significant association between SMS 
and pharmacoadherence, it was the first of its kind using patient-centered communication for 
ACT adherence in sub-Saharan Africa and was fraught with challenges.  The possibilities for 
further improvement in pharmacoadherence using technology and mobile phones specifically 
merit further exploration, and offer great opportunity to help bring an end to this deadly 
disease.  Today, 108 countries in the world are free of malaria (Feacham & Malaria 
Elimination Group, 2009).  The hope is to make it 109.   
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APPENDIX A: SMS MESSAGE SEQUENCE  
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 Day 1, dose 1: Given at the clinic – no SMS. 
 Day 1, dose 2: “Good afternoon (or evening, if appropriate)!  It’s time to take your 
malaria pills.” 
 Day 2, dose 1: “Good morning!  It’s time to take your malaria medicine.” 
 Day 2, dose 2: “Good evening!  It’s time to take your malaria pills.” 
 Day 3, dose 1: “Good morning!  It’s time to take your malaria medicine. I hope you 
feel better!” 
 Day 3, dose 2: “Good evening!  It’s time for your last malaria pills.” 
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APPENDIX B: INVITATION TO PARTICIPATE  
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APPENDIX C: DEMOGRAPHIC QUESTIONNAIRE  
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Demographic Questionnaire 
Patient’s ID#: 
 
1. Interviewer name: 
2. Patient’s name: 
3. Town of residence: 
4. Contact information: 
5. Age:  
6. Gender: (Circle one)   Male  Female 
7. Do you believe that malaria can be treated without medication?  
(Circle one)  Yes      No 
8. Have you taken malaria medication before?   (Circle one)  Yes No 
9. Do you have continuous access to a mobile phone throughout the next 3 days? 
(Circle one)  Yes No 
If yes, what is the number? 
10. When did your fever begin? (If  >1 day ago, patient cannot participate) 
(Circle one) 0-12 hours  within 12-24 hours  > 24 hours 
11. What is the highest grade in school that you have completed? 
(Circle one)  1  2  3  4  5  6  7  8  9  10  11  12  College 
12. What languages do you read and write?  (Check all that apply) 
READ:___English ___Bemba ___Other: _______________________ 
WRITE:___English ___Bemba ___Other: _______________________ 
13. Are you currently employed? (Circle one)  Yes No 
14. What is your total family monthly income in Kwacha?   
0-100K 100-500K  500-1000K   >1000K 
15. Do you own a radio? (Circle one)  Yes No  
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APPENDIX D: DATA COLLECTION TOOL  
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Medication Event Monitoring System (MEMS): AARDEX Group Ltd, 1950 Sion/ 
Switzerland; www.aardexgroup.com 
 
 MEMS cap version 6    
 
 
 
 
 
 
 
 
 
 
 
 MEMS cap unique reference number 
MEMS Communicator/Reader plugged into Windows-based computer with MEMS 
cap in reading position 
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Approval of Human Research 
 
From:            UCF Institutional Review Board #1 
         FWA00000351, IRB00001138 
 
To:                 Elinda E.  Steury and Co-PIs if applicable:  
 
Date:              February 12, 2014 
 
Dear Researcher: 
 
On 2/10/2014, the IRB approved the following human participant research until 02/09/2015 inclusive:  
 
Type of Review: UCF Initial Review Submission Form  
Project Title:  Short Message Service (SMS) reminder intervention for malaria 
medication adherence in Zambia. 
Investigator:  Elinda E.  Steury 
IRB Number:  SBE-13-09805 
Funding Agency:   
Grant Title:   
Research ID:   N/A 
 
The scientific merit of the research was considered during the IRB review. The Continuing Review 
Application must be submitted 30days prior to the expiration date for studies that were previously 
expedited, and 60 days prior to the expiration date for research that was previously reviewed at a convened 
meeting.  Do not make changes to the study (i.e., protocol, methodology, consent form, personnel, site, 
etc.) before obtaining IRB approval.  A Modification Form cannot be used to extend the approval period of 
a study.   All forms may be completed and submitted online at https://iris.research.ucf.edu .   
 
If continuing review approval is not granted before the expiration date of 02/09/2015, 
approval of this research expires on that date. When you have completed your research, please submit a  
Study Closure request in iRIS so that IRB records will be accurate. 
 
Use of the approved, stamped consent document(s) is required.  The new form supersedes all previous 
versions, which are now invalid for further use.  Only approved investigators (or other approved key study 
personnel) may solicit consent for research participation.  Participants or their representatives must receive 
a copy of the consent form(s).  
 
In the conduct of this research, you are responsible to follow the requirements of the Investigator Manual. 
 
On behalf of Sophia Dziegielewski, Ph.D., L.C.S.W., UCF IRB Chair, this letter is signed by: 
 
Signature applied by Joanne Muratori  on 02/12/2014 02:43:27 PM EST 
 
 
IRB Coordinator 
University of Central Florida Institutional Review Board 
Office of Research & Commercialization 
12201 Research Parkway, Suite 501 
Orlando, Florida 32826-3246 
Telephone: 407-823-2901 or 407-882-2276 
www.research.ucf.edu/compliance/irb.html 
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APPENDIX I: TDRC EXTERNAL COLLABORATION AGREEMENT  
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1. Were you aware that there was another group in the study whose conditions were 
different than yours? 
2. What was most helpful for you in taking the medication – the pillbox, the SMS, the 
packaging, a combination or other? 
3. Which SMS messages that you received were most helpful?  
4. Did you seek help for your illness from anyone before you came to the clinic and if 
so, who? 
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